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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the impact of the routine use of patient-reported outcomes (PROs) in clinical practice on the process of care (including
patient-physician communication, professionals’ awareness of patients’ quality of life, diagnosis and recognition rates, treatment rates,
health services and resource use, as well as patient behaviour); patients’ and professionals’ experiences of care; and health outcomes
(both generic and disease-specific, using both routinely-used clinical measures and PROs).
B A C K G R O U N D
Description of the condition
Definition of patient-reported outcome measures
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Patient-reported outcomes (PROs) measure the patient’s subjec-
tive appraisal of outcomes from their own perspective (Valderas
2008b). PRO measures offer complementary information to the
objective measurements usually collected in clinical practice to
support decision making (e.g. blood tests, imaging, functional
tests). PROs allow for systematised collection of subjective infor-
mation on health status and offer an opportunity for improving
processes and outcomes of health care. The potential benefits of
their use in clinical practice range from screening, diagnosing, and
monitoring to promotingpatient-centred care (Greenhalgh 2009).
Historically, the use of PROmeasures has been far less common in
clinical practice than in research, where PROs are often selected as
outcome measures in clinical trials (Fitzpatrick 1998; FDA 2009).
At an individual level and within the clinician-patient interface,
PROmeasures have been used for screening andmonitoring a con-
dition, such as depression symptoms; for monitoring the progress
of the patient during the course of treatment or throughout time;
and for promoting patient-centred care, by explicitly assessing the
patient’s perspective (Greenhalgh 2009).
Description of the intervention
PROs have been defined as assessments of any aspect of a patient’s
health status which are provided directly by the patient (Valderas
2008b; FDA 2009 ), usually through a questionnaire scale. PRO
is an umbrella term: it can be applied to an array of different out-
comes, including symptoms, functioning, perceived health status
and health-related quality of life (McKenna 2011).
PROs can measure generic aspects of health. One such example is
the Short Form 36, which assesses physical functioning and psy-
chological wellbeing, as well as evaluating overall health (Garratt
1993). In theory, such generic measures can be used within and
between populations, regardless of their age, gender, and dis-
ease or condition. Greater effort, however, has been devoted to
the development of PRO measures for specific diseases or condi-
tions (Garratt 2002), from common conditions such as diabetes
(Bradley 1999), to less frequent ones, including amyotrophic lat-
eral sclerosis (Gibbons 2011), and haemophilia (Arranz 2004).
The use of PROmeasures in clinical practice at a patient level can
be defined as a complex intervention, including different compo-
nents (Craig 2008). In its most basic form, in a typical PRO inter-
vention the patient is given one or more questionnaires to com-
plete, usually about their health status or health-related quality of
life, and results are then fed back to the healthcare professional.
The International Society for Quality of Life Research recently
operationalised all the aspects that should be taken into account
when trying to implement PROs in clinical practice, suggesting
a set of eight methodological steps to be followed (Snyder 2012).
These steps are establishing goals; identifying patients and settings;
selecting questionnaires; defining the administration and scoring
procedures; reporting results; facilitating score interpretation; es-
tablishing protocols to address issues raised by the questionnaires;
and assessing the eventual impact of the questionnaire in clinical
practice.
While these standardised steps can be found in almost all in-
terventions using PRO measures, considerable variation exists
between trials. For instance, instruments can be self-completed
(Rand 1988) or interviewer-administered (German 1987); com-
pleted in the clinical setting (Christensen 2005) or posted to the
patient’s home (Lewis 1996); and supported by an electronic for-
mat such as online or tablet administration (Velikova 2004) or rely
on pencil and paper (Trowbridge 1997). As for the feedback, dis-
crepancies might exist between trials as to when the information
is given to healthcare professionals, e.g. immediately before the
visit (Berry 2011); how it is given, e.g. printed form (Saitz 2003);
and by whom, e.g. available in the notes (Linn 1980). More im-
portantly, considerable differences occur regarding the amount of
feedback provided. For example, in some studies the only infor-
mation fed back to healthcare professionals were the scores each
patient obtained in the PRO measure (Bergus 2005), whereas in
other studies professionals were given information on how to ap-
ply interpretation guidelines for the scores (Rosenbloom 2007),
or treatment guidelines for the conditions detected by the PRO
measure (Saitz 2003). The number of times the patient completes
the measure and the information is then fed back to the profes-
sional can also vary considerably, from single responses (Hoeper
1984) to multiple feedbacks (Klinkhammer-Schalke 2012). Re-
flecting this, there is also variation in whether the clinician receives
the scores at a single point in time or the patient scores over a
period of time. Finally, the endpoints used to assess the impact
of PROs in clinical practice have also been a source of consider-
able discrepancy, with trials inconsistently reporting on processes
of healthcare (e.g. patient-clinician communication), outcomes of
healthcare (e.g. changes in the number or rate of symptoms or
complaints), and patient experience (e.g. overall satisfaction with
care).
How the intervention might work
The Feedback Intervention Theory (FIT) relies on the assump-
tion that behaviour is regulated through comparison with stan-
dards or goals, and that feedback can draw attention to existing
gaps (Kluger 1996). If a patient scores above the established cut-
off point in a depression screening scale, then the healthcare pro-
fessional will be made aware of this discrepancy between the de-
sired state of psychological wellbeing and the current distress ex-
perienced by the patient. FIT further postulates that once the gap
has been identified, different methods can be followed in order
to decrease it and attain the standard, including increasing the
effort currently done (Kluger 1996). This could be substantiated
by the professional using several strategies, including providing
advice, referring to other services, or altering the medication plan.
All of these are proximal outcomes that would, potentially, trigger
more distal outcomes, such as improved functioning and increased
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health-related quality of life. However, whether these outcomes
do materialise depends on a range of other contextual factors such
as the patient’s acceptance of, and adherence to, any treatment
changes and the effectiveness of that treatment.
Why it is important to do this review
In the UK, PROs are one of the cornerstones of the current reform
of the National Health Service for the transition towards an out-
comes-oriented performance model. In the US, initiatives such as
the Patient Reported Outcomes Measurement Information Sys-
tem (PROMIS 2007), funded by theNational Institutes ofHealth,
or the inclusion of PROs in electronic health record software, such
as EpicCare (EpicCare 2015) held by Group Health Cooperative,
highlight the progressive relevance these outcome measures play in
healthcare contexts. The US Department of Health and Human
Services also plans to incorporate PRO into meaningful use stan-
dards, which is likely to prompt more widespread use (Hostetter
2011).
The level of evidence for the impact of using PROs in clini-
cal practice has been mixed (Espallargues 2000; Gilbody 2001;
Greenhalgh 1999; Marshall 2006; Valderas 2008a). Valderas
2008a found that there was more evidence for impact upon the
processes rather than the outcomes of care). Specifically, there was
an increase for the rate of diagnoses and chart notations for the
conditions targeted by the interventions (e.g. diagnosis of depres-
sion in primary care). Similarly, there was also a positive effect on
the advice and education provided by the healthcare professionals.
Furthermore, Valderas 2008a identified a total of 36 endpoints
for the 28 randomised controlled trials (RCTs) included in their
systematic review, which seems to reiterate the lack of consensus
amongst researchers of how the intervention should work and thus
what constitutes a relevant indicator when using PROs in clinical
practice.
Notwithstanding the potential benefits for clinical practice, sev-
eral objections have been raised in relation to their routine use.
Healthcare professionals have expressed doubts about the clini-
cal utility of PRO measures, as they consider that little value is
added to their clinical judgement (Leydon 2011; Taylor 1996).
Healthcare professionals have also described how burdensome the
use of PROs can be, as it requires time to administer the measures
and time to learn how to analyse and interpret the results (Brown
2006), and also to integrate them into clinical practice in an effi-
cient and non-disruptive manner (Nelson 1990). Clinicians have
voiced concerns that the PRO measures might represent a threat
to the holistic nature of the patient-doctor relationship (Leydon
2011). It has also been suggested that PRO measures increase the
healthcare professional’s responsibility and burden of care, as they
might detect problems that could otherwise go unnoticed (Tavabie
2009).
Taking both the potential benefits and risks and the current health
policy initiatives into account, it becomes essential to ascertain
to what extent the use of PRO measures in clinical practice does
actually improve processes and outcomes of care. Previous reviews
have provided mixed evidence and a number of relevant studies
have been subsequently published (Valderas 2010).
O B J E C T I V E S
To assess the impact of the routine use of patient-reported out-
comes (PROs) in clinical practice on the process of care (includ-
ing patient-physician communication, professionals’ awareness of
patients’ quality of life, diagnosis and recognition rates, treatment
rates, health services and resource use, as well as patient behaviour);
patients’ and professionals’ experiences of care; and health out-
comes (both generic and disease-specific, using both routinely-
used clinical measures and PROs).
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) and cluster RCTs, where in-
dividuals (healthcare professionals or patients) or groups of indi-
viduals (including whole hospitals or practices) were randomly al-
located to either a control or an intervention group. We will not
include studies that follow a non-randomised controlled design,
such as interrupted before-and-after studies and interrupted time
series.
Types of participants
Wewill only include studieswhere participants have been recruited
in primary (e.g. health practitioner’s office) or secondary/tertiary
(e.g. hospital) care settings in order to ensure that interventions are
delivered as part of clinical care.We will exclude studies conducted
outside primary and secondary/tertiary healthcare settings (e.g.
assisted living facilities) in order to ensure that PRO information
is used for clinical purposes only. There will be no age restriction
or gender restriction, nor restrictions based on the presence or
absence of any specific disease.
Types of interventions
We will include studies if they report a replicable intervention,
where standardised or individualised PRO measures are adminis-
tered to patients and the resulting information on each individ-
ual patient is subsequently fed back to healthcare providers or pa-
tients, or both. Patient-reported outcome (PRO) measures will be
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defined as the assessment of any aspect of a patient’s health sta-
tus which is provided directly by the patient (FDA 2009), usually
through a questionnaire or scale. PROs may be used for a number
of different outcomes, including measurements of health status,
quality of life, symptoms and functioning (McKenna 2011). We
will include studies regardless of whether information was pro-
vided to patients only or to healthcare providers only or to both.
Studies will be included irrespective of whether the results were fed
back along with guidelines regarding their optimal use, or other
educational strategies. Studies will be included if they have been
conducted either during a specific procedure, for instance a surgi-
cal procedure; or during routine care, for example a primary-care
appointment. The comparison (control) condition will consist of
routine clinical practice without the feedback of any information
to the healthcare professionals.
Types of outcome measures
Primary outcomes
Our primary outcomes will include generic or disease-specific pa-
tient-reported outcomes such as health-related quality of life and
functioning.
Secondary outcome measures will be considered for the process of
care.
For the processes of health care, the following endpoints will be
considered:
• Patient-physician communication (e.g. patients’ ratings of
the quality of the communication);
• Diagnosis and recognition (e.g. number of target diagnoses
made);
• Treatment (e.g. changes to treatment);
• Health services and resource use (e.g. referral to specialist or
social care);
• Patient behaviour (e.g. compliance with treatment);
• Patient empowerment (e.g. measured using available self-
reported instruments); and
• Healthcare professionals’ awareness of patients’ quality of
life.
Other outcomes: patients’ experiences (e.g. overall satisfaction
with care) and healthcare professionals’ perceptions (e.g. attitude
and overall satisfaction with intervention); consultation length;
healthcare costs.
Adverse effects: distress following or related to PRO completion.
Search methods for identification of studies
Electronic searches
We will search the following databases: MEDLINE (In-Process &
Other Non-Indexed Citations and Ovid MEDLINE(R), 1948 to
Present, accessed through OvidSP); EMBASE (1974 to present,
accessed through OvidSP); PsycINFO (1967 to present, accessed
through OvidSP); and CINAHL (from 1981 to present, accessed
through EBSCO). The search strategy will be adapted to the spe-
cific requirements of each database, namely through the use of dif-
ferent thesaurus terms where applicable and truncation and wild-
card characters. Appendix 1 displays the search strategy for MED-
LINE. We will also search the Cochrane Effective Practice and
Organisation of Care Group specialised register, and theCochrane
Central Register of Controlled Trials (CENTRAL), the Cochrane
Database of Systematic Reviews (CDSR), and the Database of Ab-
stracts of Reviews of Effects (DARE). We will not apply language
restrictions, but searches will always be conducted in English.
Studies in languages other than English will be included.
Searching other resources
Additionally, we will identify on-going trials using the online tri-
als registry of the National Institutes of Health (US) (interven-
tional studies with interventions: “patient reported outcomes” OR
“patient reported outcome” OR “quality of life” OR “functional
status”, and all default settings); and the World Health Organi-
zation International Clinical Trials Registry Platform, using the
same search criteria. All the documents deemed as relevant, i.e.
those that are chosen to be included in the review after full text
evaluation, will be subjected to a forward citation search using
Web of Science. Previously published reviews will also be screened
for potentially-relevant references. We will contact authors of the
included studies to request information about on-going studies.
Data collection and analysis
Selection of studies
Two reviewers will independently assess each reference in title and
abstract form to ascertain whether they meet the eligibility crite-
ria. We will pilot the eligibility criteria against a random sample
of approximately 1% of all the documents received, after which
two reviewers will independently screen all of the references. Be-
cause we will be aiming for maximum sensitivity at this stage, we
will include all references assessed as relevant by at least one team
member, and will only exclude references unanimously assessed as
irrelevant.
We will follow the same strategy for the full text documents se-
lected for inclusion in the review. Again, we will conduct a sen-
sitivity strategy with a random sample of approximately 1% of
the records. As at this stage it is desirable for maximum specificity
to be achieved, we will discuss disagreements between the team
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members until consensus is reached, and we will only include ref-
erences rated as relevant by all the reviewers. We will contact a
third reviewer if consensus is not achievable. Whenever pertinent
and possible, we will contact authors for the documents that re-
ceived a discrepant rating, in order to clarify any queries. We will
document the selection process through a PRISMA flow diagram.
We will describe all the studies that fulfil the inclusion criteria in
the ’Characteristics of included studies’ table.
Data extraction and management
We will independently save all the retrieved results to a biblio-
graphic database using reference management software (Reuters
2011).Will will save all the results and remove any duplicates. Two
reviewers will independently extract data from the studies assessed
as relevant during the stage of study, and we will resolve any dis-
agreements through discussion. We will design the data extraction
form according to aspects considered to be relevant for the present
systematic review, including those suggested by the Cochrane Ef-
fective Practice and Organisation of Care Group (EPOC 2014),
and will cover the following domains:
a) Study features: clinical setting (type of setting, academic sta-
tus, and country); method of randomisation (including allocation
concealment and blinding); unit of randomisation and analysis
(patient/healthcare professional or practice/hospital); number of
arms;
b) Participants’ features: inclusion and exclusion criteria; pa-
tients’ characteristics (sociodemographic information using the
PROGRESS framework; health condition; and whether new or
known to the healthcare professional); healthcare professionals’
characteristics (profession; level of training; and previous experi-
ences with PRO measures); number of participants;
c) Intervention features: design, which may be: Single simple feed-
back (one PRO at a single time); Multiple simple feedback (one
PRO at multiple times); Single complex feedback (multiple PROs
at a single time); Multiple complex feedback (multiple PROs at
multiple times); and how PROs were used (which may be for the
intervention or for assessing outcomes, or both);
d) Administration features: method for data collection (self-re-
ported; interviewer; other); support used (pencil and paper; com-
puter-assisted; other); setting of data collection (home; clinical;
other); facilitator (no facilitator; clinical facilitator; research facili-
tator; other); other relevant administration-related characteristics;
e) Feedback: timing (associated with visits or not; scores given
before appointments, during or other); amount of information
provided (last score; previous scores; application of interpretation
guidelines; application of treatment guidelines; other); support
used (printed form; computer-assisted; other); method for feeding
back the information (handed by patients; handed by research
staff; available in notes; other);
f ) Description of the intervention: narrative description as pro-
vided by authors;
g) Results: results as provided by authors, both for processes and
outcomes of care;
h) Other features: study identifier; source of funding; ethical ap-
proval; sample size calculation; prospectively-identified barriers to
change; methodological quality.
Complex health interventions might pose specific challenges to as-
sessment (Craig 2008); and data synthesis (Shepperd 2009). Spe-
cific recommendations on how to overcome these limitations have
now been suggested, including identifying key components of the
interventions and categorising them according to those compo-
nents (Shepperd 2009). When extracting data, we will thus also
categorise the identified interventions according to their main
components.
Given the likely heterogeneity of outcomes in this review we pro-
pose to handle the outcome results in a two-stage approach. In the
first stage, we will:
1) Collate data according to the headings outlined in the ’Types
of outcome measures’ section;
2) Extract the appropriate data for each arm according to the prin-
ciple of intention to treat (i.e. according to the original random
allocation). For dichotomous data: number of patients experienc-
ing outcome/total patient number. For continuous data: total pa-
tient number, outcome mean and standard deviation (SD). We
will seek continuous data reported as mean and SD for change in
outcome from baseline (adjusted for baseline score); and, where
not available, mean absolute outcome and SD at follow up will be
recorded. For other outcome types (e.g. event rate, time to event)
we will extract data appropriately;
3) Extract outcome data for all follow-up points;
4) Extract outcome data by subgroups according to the charac-
teristics of the intervention (straight feedback of the results to the
healthcare professional; or feedback along with guidelines regard-
ing how to interpret results or other educational strategies); and
patient characteristics (educational level). When required and fea-
sible, data will be transformed in order to standardise outcomes,
for instance for differences in the direction of the scales.
We will pilot the data extraction form with a small sample of
articles finally selected. The sample will be purposively selected to
ensure heterogeneity in terms of type of studies and interventions.
All researchers will participate in this pilot. It is anticipated that
information obtained at the pilot level might inform potential
changes to the data extraction form. Extracted data will be stored
in an electronic database, which will be created using RevMan 5
(RevMan 2012).
Assessment of risk of bias in included studies
We will assess risk of bias based on the parameters suggested by
the Cochrane Collaboration (Higgins 2011), which comprises six
domains: sequence generation; allocation concealment; partici-
pants’ blinding (either patients or healthcare providers); incom-
plete outcome data; selective reporting; and other sources of bias,
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including whether the used PROs have been previously validated
for the specific setting and population. Furthermore, we will take
into account the complementary risk of bias parameters for RCTs
proposed by the Cochrane Effective Practice and Organisation of
Care Group, namely the similarity of baseline measurement, both
for outcome measures and participants’ characteristics, and the
protection against contamination (EPOC 2014a). We will classify
each parameter as high risk of bias, low risk of bias, or unclear, and
obtained information will be summarised in tabulated form, using
RevMan 5. We will express level of confidence in the evidence for
each outcome using the GRADE criteria, by assessing the type
of evidence, limitations in study design, indirectness of evidence,
unexplained heterogeneity of findings, imprecision of results, and
probability of publication bias in accordance with the guidance of
Higgins 2011. We will use the EPOC Worksheets for preparing
summary of findings using GRADE (EPOC Worksheets 2013).
As a guide, we will judge a study as at high risk of bias if more
than three of the nine individual items are considered to be high
risk.
Measures of treatment effect
We will calculate risk ratios with 95% confidence intervals (CIs)
for dichotomous data.Where studies use continuous scales ofmea-
surement to assess the effects of the intervention, mean differences
(MD) with 95% CIs will be used; or, when studies use different
scales or measurements, we will use the the standardised mean
difference (SMD). Where studies use other outcome metrics, e.g.
rates of events or time to event, we will seek the appropriate overall
measure of effect, e.g. rate risk ratio, hazard ratio.
Unit of analysis issues
If any cluster randomised clinical trials are included, we will con-
tact the trial authors to obtain an estimate of the intra-cluster cor-
relation (ICC) where appropriate adjustments for the correlation
between participants within clusters have not been made, or im-
pute it using estimates from the other included trials, or from sim-
ilar external trials. We will inflate the trial standard errors. We will
try to either reduce the size of trials to its ‘effective sample size’
or recalculate the effects using an approximately correct analysis
and using design effect calculated from the ICC (Higgins 2011).
Whenever studies include more than one intervention arm, we
will seek to combine arms to create a single pair-wise comparison
or we will conduct pair-wise comparisons by comparing each in-
tervention arm to the control arm (splitting the control arm sam-
ple size).
Dealing with missing data
We will attempt to obtain missing data by contacting the authors
of the trials. If data remain unavailable (allowing for a maximum
waiting period of onemonth for a reply), the impact of themissing
data will be discussed (see ’Sensitivity analysis’ below).
For dichotomous outcomes, we will make analyses according to
the intention-to-treat method (Higgins 2011), which includes all
participants irrespective of compliance or follow-up. For the pri-
mary analyses, we will assume that participants lost to follow up
are alive, and have no serious adverse events. For continuous out-
comes we will perform available patient analysis and include data
only on those for whom results are known (Higgins 2011). If it
is not possible to obtain SDs either from authors or by calcula-
tion, the missing data will be imputed by using SDs from other
included trials, specifically trials with a low risk of bias (Furukawa
2006).
Assessment of heterogeneity
First, we will explore clinical heterogeneity across studies by com-
paring the population, intervention and control arms.Wewill then
explore statistical heterogeneity observed in the trials both by vi-
sual inspection of a forest plot, and by using a standard Chi² value
with a significance level of P = 0.10. We will assess heterogeneity
using the I² statistic. An I² estimate greater than or equal to 50%
with a statistically significant value for Chi², will be interpreted
as evidence of a substantial problem with heterogeneity (Higgins
2011). If this is the case, we will explore reasons for heterogeneity.
If there is high inconsistency, and clear reasons for this are found,
we will present data separately.
Data synthesis
We will perform data synthesis according to recommendations
in the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011), using RevMan 5 (RevMan 2012) and STATA v13
(StataCorp 2013). Given the likely heterogeneity of data in this
review we propose to handle the outcome results in a two-stage
approach. In the first stage, we will: (1) collate data according to
the headings outlined in the ’Types of outcome measures’ section;
(2) according to outcome, extract the appropriate data for each
arm according to the principle of intention to treat (i.e. according
to the original random allocation). For dichotomous data: number
of patients experiencing outcome/total patient number. For con-
tinuous data: total patient number, outcome mean and standard
deviation (SD). We will seek continuous data reported as mean
and SD for change in outcome frombaseline (adjusted for baseline
score) and where not available, mean absolute outcome and SD
at follow up will be recorded. For other outcome types (e.g. event
rate, time to event) we will extract data appropriately; (3) we will
extract outcome data at all follow-up points; (4) where reported,
we will also extract this outcome data by subgroups according to
the characteristics of the intervention (straight feedback of the re-
sults to the healthcare professional; feedback along with guidelines
regarding how to interpret results or other educational strategies)
and patient characteristics (educational level).
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In the second stage, based on the quality and consistency of out-
come reporting, we will decide to synthesise results across stud-
ies using either a formal quantitative meta-analytic approach or a
more descriptive approach that focuses on summarising the size
and direction of treatment effect separately for each individual
study. If enough information is provided by the studies included
in the review, the potential impact of moderator variables will be
considered through meta-regression analysis. When required and
feasible, data will be transformed in order to homogenise out-
comes, for instance for differences in the direction of the scales.We
will employ the I² statistic to assess heterogeneity (Higgins 2003).
Due to the expected heterogeneity of the data, we will employ
random-effects methods (Deeks 2008). We will also perform the
meta-analysis using a fixed-effect model and if there are discrep-
ancies between results from the two models, both sets of results
will be presented, otherwise we will report the results from the
random-effects model only. Further specification of the methods
for analysis (e.g. MD versus WMD) will be tailored to the type of
outcome data. If the heterogeneity of studies is found to be sub-
stantial, i.e. I² above 50%, we will not perform a meta-analysis,
although we will still quantify the results by calculating effect sizes
and will apply a structured synthesis approach (EPOC 2014b).
Subgroup analysis and investigation of heterogeneity
No interactions or effect modifiers are being hypothesised in this
review, and therefore we do not pre-specify stratified meta-analysis
or meta-regression analyses (with exception of risk of bias - see
’Sensitivity analysis’ below). However, where conducted, we will
seek to data extract and report trial level subgroup analyses to
inform hypothetical models of subgroup analysis for future meta-
analyses.
Sensitivity analysis
We will conduct a sensitivity analysis by verifying the impact that
the exclusion of certain studies (e.g. those with high overall risk
of bias (see definition above), and those with large samples) has
on the overall results. Whenever relevant and possible we will
contact study authors in order to obtain missing information,
allowing for a maximum waiting period of one month for a reply.
Where authors fail to provide missing information, existing data
will be analysed and the hypothetical impact of the missing data
examined as sensitivity analysis. Finally a sensitivity analysis will be
undertaken to examine the impact varying the ICC for reanalysis
of cluster randomised trials.
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Appendix 1. MEDLINE search strategy
#1 exp “outcome assessment” (Health Care)/
#2 Outcome? adj2 assessment.tw
#3 patient reported outcome?.tw
#4 outcome? measure?.tw
#5 exp health status/
#6 health status.tw
#7 exp “quality of life”/
#8 quality of life.tw
#9 (QL or QoL or HRQL or HRQoL).tw
#10 (function* adj2 (status or psychological or mental or physical or social)).tw
#11 disabilit*.tw
#12 exp “Activities of Daily Living”/
#13 activities of daily living.tw
#14 (wellbeing or well being).tw
#15 exp happiness/
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(Continued)
#16 (happi* or happy).tw
#17 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16
#18 (“value in health” or “value health” or “quality of life research” or “qual lif res” or “health & quality of life outcomes” or “health
qual lif out”).jn












#31 exp health surveys/
#32 survey?.tw
#33 20 or 21 0r 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32
#34 (symptom? adj2 (assessment or index or indices or instrument? or measure? or profile? or rating? or report* or scale? or schedule?
or scor* or survey?)).tw
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(Continued)
#40 self report*.tw
#41 36 or 37 or 38 or 39 or 40
#42 (Validation Studies or Comparative Study).pt. or exp psychometrics/ or psychometr*.tw. or clinimetr*.tw. or clinometr*.tw. or
exp observer variation/ or observer variation.tw. or exp Health Status Indicators/ or exp reproducibility of results/ or reproducib*.
tw. or exp discriminant analysis/ or reliab*.tw. or unreliab*.tw. or valid*.tw. or coefficient.tw. or homogeneity.tw. or homogeneous.
tw. or internal consistency.tw. or (cronbach* and (alpha or alphas)).tw. or (item and (correlation* or selection* or reduction*)).tw.
or agreement.tw. or precision.tw. or imprecision.tw. or precise values.tw. or test-retest.tw. or (test and retest).tw. or (reliab* and (test
or retest)).tw. or stability.tw. or interrater.tw. or inter-rater.tw. or intrarater.tw. or intra-rater.tw. or intertester.tw. or inter-tester.tw. or
intratester.tw. or intra-tester.tw. or interobserver.tw. or inter-observer.tw. or intraobserver.tw. or intraobserver.tw. or intertechnician.tw.
or inter-technician.tw. or intratechnician.tw. or intra-technician.tw. or interexaminer.tw. or inter-examiner.tw. or intraexaminer.tw. or
intra-examiner.tw. or interassay.tw. or inter-assay.tw. or intraassay.tw. or intra-assay.tw. or interindividual.tw. or inter-individual.tw. or
intraindividual.tw. or intra-individual.tw. or interparticipant.tw. or inter-participant.tw. or intraparticipant.tw. or intra-participant.
tw. or kappa.tw. or kappa’s.tw. or kappas.tw. or repeatab*.tw. or ((replicab* or repeated) and (measure or measures or findings or
result or results or test or tests)).tw. or concordance.tw. or (intraclass and correlation*).tw. or discriminative.tw. or known group.tw. or
factor analysis.tw. or factor analyses.tw. or dimension*.tw. or subscale*.tw. or (multitrait and scaling and (analysis or analyses)).tw. or
item discriminant.tw. or interscale correlation*.tw. or error.tw. or errors.tw. or individual variability.tw. or (variability and (analysis or
values)).tw. or (uncertainty and (measurement or measuring)).tw. or standard error of measurement.tw. or sensitiv*.tw. or responsive*.
tw. or ((minimal or minimally or clinical or clinically) and (important or significant or detectable) and (change or difference)).tw.
or (small* and (real or detectable) and (change or difference)).tw. or meaningful change.tw. or ceiling effect.tw. or floor effect.tw. or
Item response model.tw. or IRT.tw. or Rasch.tw. or Differential item functioning.tw. or DIF.tw. or computer adaptive testing.tw. or
item bank.tw. or cross-cultural equivalence.tw
#43 33 or 41 or 42
#44 35 and 43
#45 (15-dimensional health-related quality of life measure or Affect Balance Scale or APMG-15 or Attitudes Professionnelles des
MedecinsGeneralistes or APPO-09 or Attitudes Professionnelles des Pharmaciens d’Officine or AQoL or Assessment ofQuality of Life
or ATD-PA or Assistive Technology Device Predisposition Assessment or AUQUEI or Brief Hospice Inventory or CDC HRQOL-
14 or (Centers for Disease Control and Prevention Health-Related Quality of Life Measure) or (Child Health and Illness Profile) or
Child Health Questionnaire or COOP-C or WONCA or Client Satisfaction Questionnaire or Duke Health Profile or DUSOCS or
(Duke Social Support and Stress Scale) or DUSOI or Duke Severity of Illness Checklist or EQ-5D or Euroqol EQ-5D or Family
System Test or FKB 20 or BIQ-20 or Fragebogen zum Korperbild or Body Image Questionnaire or Functional Limitations Profile
or Functional Status Questionnaire or gars or Groningen Activity Restriction Scale or ghsq or Glasgow Health Status Questionnaires
or gqol or Global Quality of Life Scale or Grogono Health Index or halex or (Health and Activity Limitation Index) or Health
Assessment Questionnaire or hdlf or (Health and Daily Living Form) or Health Utilities Index or iadl or Instrumental Activities of
Daily Living or Illness Behavior Questionnaire or Indice de Resistencia a la Enfermedad or iwls or Impact of Weight Loss Scale or
KIDSCREEN or kindl or Revidierter KINDer Lebensqualitatsfragebogen or London Handicap Scale or Modified Barthel Index or
mcsi or Multidimensional Caregiver Strain Index or Mental Health Inventory or mhiq or McMaster Health Index Questionnaire or
mhlc or Multidimensional Health Locus of Control Scales or Moss Kitchen Assessment Revised or MOS-SSS or MOS Social Support
Survey or mtap or Multidimensional Task Ability Profile or Nottingham Health Profile or oars or (Older Americans Resources and
Services Multidimensional Functional Assessment Questionnaire) or pedsql or Pediatric Quality of Life Inventory or PGC Morale
Scale or Philadelphia Geriatric Center Morale Scale or Patient Generated Index or pgwbi or Psychological General Well-Being Index
or piads or Psychosocial Impact of Assistive Device Scale or Quality of Life Profile for the Chronically Ill or Palliative Care Outcome
Scale or pqol or Perceived Quality of Life scale or psms or Physical Self-Maintenance Scale or qalys or Quality Adjusted Life Years or
ql-index or Spitzer’s Quality of Life Index or (Ferrans and Powers Quality of Life Index) or qlq-e or (Quality of Life Questionnaire
and evans) or qlsi or Quality of Life Systemic Inventory or qodd or (Quality of Dying and Death) or qoli or Quality of Life Inventory
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(Continued)
or qols or Flanagan’s Quality of Life Scale or (Quality of End-of-life care and Satisfaction with Treatment scale) or Quebec User
Evaluation of Satisfaction with assistive Technology or Quality of Well Being scale or QWB-SA or Quality of Well-Being scale Self-
Administered or sas-sr or Social Adjustment Scale - Self Report or sat-p or Satisfaction profile or Screen for Caregiver Burden or
SCSORF or Santa Clara Strength of Religious Faith Questionnaire or seiqol or Schedule for the Evaluation of Individual Quality of
Life or sf-12 or sf-12v2 or sf-12 health survey or sf-12v2 health survey or sf-36 or sf-36 health survey or sf-36v2 or sf-36v2 health
survey or Sickness Impact Profile or sisc or (Structured Interview for Symptoms and Concerns) or Silver Lining Questionnaire or sqlp
or Subjective Quality of Life Profile or (sss-30 or sss-15) or Service Satisfaction Scale or stas or Support Team Assessment Schedule or
SWED-QUALor SwedishHealth-RelatedQuality of Life Survey or TAAQOLorTNO-AZLQuestionnaire for Adult’sHealth-related
Quality of Life or TACQOL or TNO AZL Children’s Quality of Life or TAPQOL or TNO-AZL Preschool children Quality of Life
questionnaire or TEAQV or Tableau d’Evaluation Assistee de la Qualite de Vie or TedQL or Quality of Life measure for children aged
3-8 years or TSQM or Treatment Satisfaction Questionnaire for Medication or wanq or Wyke’s Assessment of Need Questionnaire
or Ways of Coping Questionnaire or WCHMP or (Warwick Child Health and Morbidity Profile) or who-5 or WHO Five Well-
Being Index orWHOQOL-100 orWHOQOL-BREF orWorld HealthOrganization Quality of Life assessment instrument orWork
Limitations Questionnaire or WPAI or (Work Productivity and Activity Impairment Questionnaire) or YQOL or Youth Quality
of Life Instrument or ZungSAS or Zung Self-rating Anxiety Scale or (PEDI-MCAT or Pediatric Evaluation of Disability Inventory
Multidimensional Computer-Adaptive Testing or Salience of Lifestyle Index or (SLDS or Satisfaction with Life Domains Scale) or
(GFRS or Geriatric Functional Rating Scale) or (GQLQ or Geriatric Quality of Life Questionnaire) or (QOLPSV or Quality of Life
Profile Seniors- Version) or (MVQOLI orMissoula VITASQuality of Life index) or (MYMOP orMeasure YourselfMedical Outcome
Profile) or (PSQL or Profile of the Subjective Quality of Life) or (MPOC or Measure of Processes of Care) or Fatigue Impact Scale or
(HCIQ or Health Consequences of Injury Questionnaire) or (MAHSC or Multi-Attribute Health Status Classification) or (RDRS-
2 or Rapid Disability Rating Scale 2) or (AM-PAC CAT or Boston University Activity Measure for Post Acute Care) or Aging Males
Symptoms Scale or Barthel Index or (Brief IPQ or Brief Illness PerceptionQuestionnaire) or (ComQOL or Comprehensive Quality of
Life scale) or Environmental Status Scale or (FEFA or Frail Elderly Functional Assessment questionnaire) or Functional Impairment
Scale or Functional Status Index or (GAIS or Global Adjustment to Illness Scale) or (GHRI or General Health Rating Index) or
(GQLI or Goteborg Quality of Life Instruments) or (G-QOL or Global Quality Of Life Score) or How Are You? Scale or Health
Behavior Scale or (HOOP or Housing Options for Older People) or howRu or Health Practice Index or (HPLP or Health-Promoting
Lifestyle Profile) or Health Perceptions Questionnaire or Illness Perception Questionnaire or (IPQ-R or Revised Illness Perception
Questionnaire) or Illness Severity score or (LASA-HD or (Linear Analogue Self-Assessment - Holmes and Dickerson)) or (LASA-
PB or (Linear Analogue Self-Assessment - Priestman and Baum)) or Linear Analogue Self-Assessment or (MQLQ or Multilingual
Quality of Life Questionnaire) or (MQOL or McGill Quality of Life questionnaire) or (PEDI or Pediatric Evaluation of Disabilty
Inventory) or (PEPS or Patient Evaluated Problem Score) or (PSDI or Physical Symptoms Distress Index) or (QLPI or Quality of Life
Profile Inventory) or (QLRS or Quality of Life Rating Scale) or (QOL-Q or Qualite de la Vie Questionnaire) or (R36IHS or Rand
36-Item Health Survey) or Rehabilitation Activities Profile or Reintegration to Normal Living or (SBQOL or Smithkline Beecham
Quality of Life scale) or (SF-20 or MOS Short Form) or (SIP-HMS or Sickness Impact Profile - Home Management Scale) or (SIQR
or Symptom Impact Questionnaire) or (SQLI or Sendera Quality of Life Index) or (Selby’s QL Uniscale or Selby’s quality of life
uniscale) or Treatment Response Scale or Visual Analogue Scale or Visual Analogue Thermometer or (VSQLQ or Vital Signs Quality
of Life Questionnaire) or World Health Organization Symptom Checklist or (WI HSS QOL or Wisconsin HSS Quality of Life
Inventory) or (MRFA or Medical Rehabilitation Follow Along) or Satisfaction with Illness scale) or (ONYCHO or Onychomycosis
Quality of Life questionnaire or Cardiac Depression Scale or Cardiac Health Profile or dasi or Duke Activity Status Index or milq or
Multidimensional Index of Life Quality or PACT-Q or Perception of Anticoagulant Treatment Questionnaire or APQLQ or Angina
Pectoris Quality of Life Questionnaire or MacNew or MacNew Heart Disease Health-relatedQuality of Life Questionnaire or Seattle
Angina Questionnaire or Chronic Heart Failure Questionnaire or kccq or Kansas City Cardiomyopathy Questionnaire or mlhf or
Minnesota Living with Heart Failure Questionnaire or Quality of Life at the End of Life Measure or qual-e or Cambridge Pulmonary
Hypertension Outcome Review or chal or Quality of Life Questionnaire for Arterial hypertension or hyper 31 or Hypertension
Health Status Inventory or minichal or Short form of Quality of Life Questionnaire for Arterial hypertension or MacNew Heart
Disease Health-related Quality of Life Questionnaire or Myocardial Infarction Dimensional Assessment Scale or ql-sp or Quality
of Life Questionnaire for Cardiac Spouses or Assessment of Quality of Life in lower limb arteriopathy or clau-s or Claudication
Scale or Edinburgh Claudication Questionnaire or Peripheral Artery Questionnaire or Walking Impairment Questionnaire or pact-
q or Perception of Anticoagulant Treatment Questionnaire or Canadian Neurological Scale or mrs-si or Structured Interview for
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the Modified Rankin Scale or NEWSQOL or Newcastle Stroke-specific Quality of Life measure or nihss or National Institutes of
Health Stroke Scale or SAQOL-39 or (Stroke and Aphasia Quality of Life Scale) or Stroke Impact Scale & Stroke Toolbox or ss-
qol or Stroke-Specific Quality Of Life measure or Stroke-Specific Quality Of Life or avvq or Aberdeen Varicose Veins Questionnaire
or VEINES QOL Sym or (VEnous INsufficiency Epidemiological and Economic Study) or PACT-Q or (Health Complaints Scale
or (HHAQ or Heart Health Assessment Questionnaire) or (HPPQ or Heart Patients Psychological Questionnaire) or (HRQOL-
Hy or Health-related Quality of Life questionnaire for hypertensive patients) or (HTSC or Heart Transplant Symptom Checklist)
or (JQLIS or Jachuck’s Quality of Life Impairment Scale) or (MCLQ or Milwaukee Cardiovascular Life Quality questionnaire) or
(MPFH or Medical-Psychological Questionnaire for Heart Patients) or (NYHA-FCS or New York Heart Association Functional
Classification Scale) or (PHTQ or Perception of Heart Transplantation Questionnaire) or (PSOCS or (Processes, Structures, and
Outcomes of Cardiac Surgery)) or (QLIHD or Quality of Life Ischemic Heart Disease) or (QLIS-H or Quality of Life Impairment
Scale Hypertension) or Quality of Life Impairment Scale - Hypertension or Rose Cardiovascular Questionnaire or (SSAP or Subjective
Symptoms Assessment Profile) or (UBQ-H or Utility Based Quality of life - Heart questionnaire) or Frenchay Activities Index or (R-
ADL or Rivermead ADL Scale) or (SA-SIP30 or Stroke Adapted 30-item SIP version))) or (MPQOL or Miami Pediatric Quality of
Life Questionnaire Parent Scale or Oxford Hip Score or Cystic Fibrosis Questionnaire or PIQoL-AD or Parents’ Index of Quality of
Life in AtopicDermatitis or QoLIAD or Quality of Life Index for AtopicDermatitis or lsia or Life Satisfaction Index for Adolescents or
A36Hemofilia-QoL or Hemophilia-specific health-related quality of life questionnaire or QUALHEMO or Haemophilia age group-
specific Quality of life questionnaire) or (dhsi or Digestive Health Status Instrument or GIQLI or Gastrointestinal Quality of Life
index or Celiac Disease Questionnaire or Cystic Fibrosis Questionnaire or GSRS or Gastrointestinal Symptom Rating Scale or QLI-
CP or Quality of Life Index for Colostomy Patients or FIQL or Fecal Incontinence Quality of Life scale or fisi or Fecal Incontinence
Severity Index or ndb score or Neurogenic Bowel Dysfunction score or dsiq or (Digestive Symptoms and Impact Questionnaire) or
GERD-HRQL or Gastroesophageal Reflux Disease Health Related Quality of Life scale or GSAS or Gastroesophageal Reflux Disease
Symptom Assessment Scale or gsfq or GERD Symptom Frequency Questionnaire or GSRS-self or Gastrointestinal Symptom Rating
Scale self-administered version or HBQOL or Heartburn-Specific Quality of Life Instrument or ndi ndi-sf or Nepean Dyspepsia
Index or PAGI-QOL or Patient Assessment of Upper Gastrointestinal Disorders-Quality of Life or PAGI-SYM or Patient Assessment
of Gastrointestinal Disorders Symptom Severity Index or QOLRAD or (Quality Of Life in Reflux and Dyspepsia) or Reflux-Qual or
Quality of LifeQuestionnaire inGastroesophageal RefluxorGCSI orGastroparesis Cardinal Symptom Index or PAGI-QOLorPatient
Assessment of Upper Gastrointestinal Disorders-Quality of Life or PAGI-SYM or Patient Assessment of Gastrointestinal Disorders
Symptom Severity Index or GSRS-self or Gastrointestinal Symptom Rating Scale self-administered version or IBDQ or Inflammatory
Bowel Disease Questionnaire or IBDQOL or Inflammatory Bowel Disease Quality of Life Questionnaire or IMPACT III or RFIPC
or Rating Form of IBD Patient Concerns or FDDQL or Quality of Life Questionnaire for Functional Digestive Disorders or GSRS or
IBS-36 or IBS-QOL or Irritable Bowel Syndrome - Quality Of Life or CLDQ or Chronic Liver Disease Questionnaire or (GRDS or
Gastroesophageal Reflux Data Sheet or Harvey-Bradshaw Index or (HRQOL-GERD or Health-related Quality of Life questionnaire
for individuals with gastroesophageal reflux disease) or (IBDSI or Inflammatory Bowel Disease Stress Index) or (McMaster IBDQ or
McMaster Inflammatory bowel disease questionnaire) or (WISP or Well-being Index for Surgical Patients) or (QLDUP or Quality of
Life in Duodenal Ulcer Patients))) or (MCAS or Modified Caregiver Appraisal Scale or BCTSQ or (Brigham and Women’s Hospital
Carpal Tunnel Syndrome Questionnaire) or Boston Carpal Tunnel Syndrome Questionnaire or OFDQ or Osteoporosis Functional
Disability Questionnaire or PRWE or Patient-RatedWrist Evaluation or NBD score or Neurogenic Bowel Dysfunction score or Qual-
OT or Quality of Life in Occupational Therapy or QUALIVEEN or AWQV2 or Amphetamine Withdrawal Questionnaire Version
2 or CMDQ or Common Mental Disorder Questionnaire or Smoker Anchored Withdrawal Grid or Smoker Complaint Scale or
STAR-SMOQ55 or Situation X Trait Adaptative Response Smoking Motivation questionnaire or TLFB or Timeline Followback
Method) or (ICD-QOL or Implantable Cardioverter Defibrillator Quality of Life Questionnaire or AcroQoL or Acromegaly Quality
of Life questionnaire or ADDQoL or Audit of Diabetes Dependent QoL or D-FISQ or (Diabetes Fear of Injecting and Self-testing
Questionnaire) or das-3 or Diabetes Attitude Scale or Diabetes Care Profile or dcsq or Diabetes Clinic Satisfaction Questionnaire
or Diabetes Empowerment Scale or dfbs or Diabetes Family Behavior Scale or Diabetic Foot Ulcer Scale or DHP-1 or DHP-18 or
Diabetes Health Profile or DiabMedSat or Diabetes Medication Satisfaction or DIMS or Diabetes Impact Measurement Scales or
Diabetes Knowledge Questionnaire or Diabetes Knowledge Test or Diabetes Mellitus History or Diabetes Productivity Measure or
DQLCTQ or Diabetes Quality of Life Clinical Trial Questionnaire or dqol or Diabetes Quality of Life measure or dqoly or Diabetes
Quality of Life for Youth scale or dsc-r or Diabetes Symptom Checklist-Revised or Diabetes SymptomMeasure or (DSMP or DSMP-
F) or Diabetes Self-Management Profile or DSQOLS or Diabetes specific quality of life scale or DTSQ-for-FIT20 Status or DTSQ-
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for-FIT20 Change or Functional Insulin Treatment Satisfaction Questionnaire or dtsq or dtsqs or dtsqc or Diabetes Treatment
Satisfaction Questionnaire or Hypoglycemia Fear Survey or Impact of Child Illness scale or itsq or Insulin Treatment Satisfaction
Questionnaire orMultidimensionalDiabetesQuestionnaire ormnsi orMichiganNeuropathy Screening Instrument orNorfolkQOL-
DN or Norfolk Quality of Life Questionnaire - Diabetic Neuropathy or Problem Areas in Diabetes scale or PedsQLDiabetes Module
or Pediatric Quality of Life Inventory Diabetes Module or psit or Patient Satisfaction with Insulin Therapy questionnaire or Studying
theHurdles of Insulin Prescription or w-bq orWell-BeingQuestionnaire or we-care or (WEll-being and Satisfaction of CAREgivers of
Children with Diabetes Questionnaire) or go-qol or Graves’ Ophtalmopathy Quality of Life Questionnaire or EORTC QLQ-OV28
or (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Ovarian Cancer Module) or QLQ-
OV28 or (PMDI or Personal Models of Diabetes Interview or (QoL-AGHDA orQuality-of-lifemeasure in growth hormone-deficient
adults))) or (avft or Arabic Visual Function Test or covd or College of Optometrists in Vision Development Quality of Life Outcomes
Assessment or Impact of Vision Impairment or LVQOL or Low Vision Quality-of-Life Questionnaire or NEI-VFQ25 orNational Eye
Institute Visual Function Questionnaire-25 orObjectif Douleur EnOphtalmologie et Neuro-ophtalmologie or osdi or Ocular Surface
Disease Index or Ocular Surface Disease Questionnaire or QOLVFQ or (Quality of Life and Vision Function Questionnaire) or vf-
14 or Visual Function Index or ideel or Impact of Dry Eye on Everyday Life or comtol or Comparison of Ophthalmic Medications
for Tolerability Questionnaire or glauqol or Glaucoma Quality of Life Questionnaire or go-qol or Graves’ Ophtalmopathy Quality
of Life Questionnaire or NEI-RQL-42 or National Eye Institute - Refractive Error Quality of Life Instrument - 42 or Refractive
Error Quality of Life Instrument or (Refractive Status and Vision Profile) or (Glaucoma Symptom Scale or Measure of outcome in
ocular disease or (VCM1 or Vision Core Measurement))) or (Cardiff Breast Scales or NEMOQC or New Mother Quality of Care
questionnaire or ORTHO BC-SAT or ORTHO Birth Control Satisfaction Assessment Tool or EHP-30 or Endometriosis Health
Profile-30 or BISF-W or Brief Index of Sexual Functioning for Women or CSFQ or Changes in Sexual Functioning Questionnaire
or DISF or Derogatis Interview for Sexual Functioning or DSFI or Derogatis Sexual Functioning Inventory or FSAQ or Fallowfield’s
Sexual Activity Questionnaire or FSFI or Female Sexual Function Index or Index of Sexual Life or MFSQ or McCoy Female Sexuality
Questionnaire or Personal Experiences Questionnaire or SPFS or Self-Perception of Female Sexuality or WSFQ or Watts Sexual
Function Questionnaire or UFS-QOL or (Uterine Fibroid Symptom andQuality of Life questionnaire) orHOIQ orHerpesOutbreak
Impact Questionnaire or Herpes Symptom Checklist or RGHQoL or Recurrent Genital Herpes Quality of Life Questionnaire or
UFS-QOL or (Uterine Fibroid Symptom and Quality of Life questionnaire) or MENQOL or Menopause-specific Quality of Life
Questionnaire or Menopause Representations Questionnaire or Menopause Rating Scale or UQOL or Utian Quality of Life scale or
Women’s Health Questionnaire or Menorrhagia Outcomes Questionnaire or Menstrual Distress Questionnaire or EORTC QLQ-
OV28 or QLQ-OV28 or (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Ovarian
Cancer Module) or EORTC QLQ-CX24 or QLQ-CX24 or (European Organization for Research and Treatment of Cancer Quality
of Life Questionnaire - Cervical Cancer Module) or (QOL-SPE or Quality-Of-Life instrument for Symptomatic Patients with
Endometriosis or (HRQOL-E or Health-relatedQuality of Life instrument for symptomatic patients with endometriosis) or Index of
Sexual Function or (U-IIQ or Urge-Incontinence Impact Questionnaire) or (UIWQ or Urinary Incontinent Women Questionnaire)
or (U-UDI or Urge-Urinary Distress Inventory) or Urogenital Distress Inventory or Genital HerpesMeasure)) or (MPQOL orMiami
Pediatric Quality of Life Questionnaire Parent Scale or A36 Hemofilia-QoL or Hemophilia-specific health-related quality of life
questionnaire or QUAL HEMO or Haemophilia age group-specific Quality of life questionnaire or qol-e) or (AIMS2 or Arthritis
Impact Measurement Scales or ASQoL or Ankylosing Spondylitis Quality of Life Questionnaire or BASDAI or Bath Ankylosing
Spondylitis Disease Activity Index or BASFI or Bath Ankylosing Spondylitis Functional Index or CHAQ or Childhood Health
Assessment Questionnaire or Foot Function Index or JAQQ or Juvenile Arthritis Quality of Life Questionnaire or MACTAR or
McMaster Toronto Arthritis Patient Preference Disability Questionnaire or Oxford Elbow Score or Oxford Hip Score or Oxford
Shoulder Score or PSAQoL or Psoriatic Arthritis Quality of Life Instrument or QOL-RA or Quality of Life-Rheumatoid Arthritis
Scale or RAQoL or Rheumatoid Arthritis Quality of Life Questionnaire or Attitudes to Asthma Questionnaire or Adolescent Asthma
Quality of Life Questionnaire or AAQOL or Asthma Bother Profile or Asthma Control Diary or Asthma Control Questionnaire or
acss or Asthma Control Scoring System or Asthma Control Test or About My Asthma or aq30 or aq20 or Airways Questionnaire
or aqlq or Asthma Quality of Life Questionnaire or AQLQ-M or (Asthma Quality of Life Questionnaire and Marks) or AQLQ-
NAA or Asthma Quality of Life Questionnaire for Native American Adults or Asthma Symptom Checklist or Asthma Self-Efficacy
Scale or asui or Asthma Symptom Utility Index or Bronchial Hyperresponsiveness Questionnaire or caqs or Childhood Asthma
Questionnaires or Childhood Asthma Questionnaire or Inhaled Corticosteroid Questionnaire or KASE-AQ or (Knowledge, Attitude
and Self-efficacy Asthma Questionnaire) or LWAQ or Living with Asthma Questionnaire or MiniAQLQ or Mini Asthma Quality
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of Life Questionnaire or PACQLQ or Paediatric Asthma Caregiver’s Quality of Life Questionnaire or PAQLQ or Paediatric Asthma
Quality of Life Questionnaire or QLQ-Asthma or Questionnaire for the Assessment of Quality of Life in Asthma Patients or SGRQ or
St George’s Respiratory Questionnaire or PIQoL-AD or Parents’ Index of Quality of Life in Atopic Dermatitis or QoLIAD or Quality
of Life Index for Atopic Dermatitis or GO-QOL or Graves’ Ophtalmopathy Quality of Life Questionnaire or AIDS-HAQ or AIDS
Health Assessment Questionnaire or HAT-QoL or HIV Symptom Index or HIV-SQUAD or Symptom Quality of Life Adherence
or HIV Overview of Problems - Evaluation System or MOS-HIV or Medical Outcome Study-HIV Health Survey or MPQOL or
Miami Pediatric Quality of Life Questionnaire Parent Scale or MQOL-HIV or Multidimensional Quality of Life questionnaire for
HIV AIDS or Multidimensional Quality of Life questionnaire for HIV or SLEQoL or Systemic Lupus Erythematosus Quality of Life
Questionnaire or EDSS or Expanded Disability Status Scale or HAQUAMS or Hamburg Quality of Life Questionnaire Multiple
Sclerosis or MSIS-29 or Multiple Sclerosis Impact Scale or MSQLI or Multiple Sclerosis Quality of Life Inventory or MSQOL-
54 or Multiple Sclerosis Quality of Life-54 or MSWS-12 or Multiple Sclerosis Walking Scale or PS-MS or Performance Scales for
Multiple Sclerosis or Qual-OT or Quality of Life in Occupational Therapy or SI-MS or Symptom Inventory for Multiple Sclerosis
or Myasthenia Gravis Questionnaire or (SLDI or Systemic Lupus International Coordinating Committee or (SLDI and American
College of Rheumatology) or (SLICC ACR or damage Index) or (SLEDAI or Systemic Lupus Erythematosus Disease Activity Index)
or Rheumatology Attitudes Index or (MHAQ or Modified Health Assessment Questionnaire) or (MSOK or Patient-based Measure
of the Severity of Osteoarthritis of the Knee) or (SAJC or Self-Administered Joint Count) or (THAOEQ or Total Hip Arthoplasty
Outcome Evaluation Questionnaire) or (PPDQ or Patient Preference Disability Questionnaire) or (ACAAI-LQ or American College
of Allergy, Asthma & Immunology - Life Quality) or (Acute AQLQ or Acute Asthma Quality of Life Questionnaire) or Life Activity
questionnaire for Childhood Asthma or (LAQ-AA or Life Activities Questionnaire for Adult Asthma) or (LAQ-CA or Life Activities
Questionnaire for Childhood Asthma) or LIFE-Aor Life Activities Questionnaire for Adult Asthma or LIFE-Cor Life Activities
Questionnaire for Childhood Asthma or (PCAQ or PerceivedControl of AsthmaQuestionnaire) or Tasmanian Asthma survey or HIV
Assessment Tool or (HIV-QL31 or HIV-Quality of Life - 31 items) or (SymptomDistress Module or HIV Symptom Index) or Keitel
Functional Assessment or Simple Shoulder Test)) or (BPHII or Benign Prostatic Hyperplasia Impact Index or DAN-PSS-1 or Danish
Prostatic Symptom Score or I-PSS or International Prostate Symptom Score or ICSmale or ICSQoL or International Continence
Society-Benign Prostatic Hyperplasia or Symptom Problem Index or UROLIFE or BPHQoL9 or Benign Prostatic Hypertrophy
Health-Related Quality of Life Questionnaire or NIH-CPSI or National Institute of Health Chronic Prostatitis Symptom Index
or BSFQ or Brief Sexual Function Questionnaire or CMSH-SFQ or (Center for Marital and Sexual Health Sexual Functioning
Questionnaire) or Erectile Dysfunction Inventory of Treatment Satisfaction or FSHQ or Florida Sexual History Questionnaire or iief
or iief-5 or International Index of Erectile Function or Index of Sexual Life or mshq or Male Sexual Health Questionnaire or (Self-
Esteem and Relationship Questionnaire) or Sexual Function Index or slqq or Sexual Life Quality Questionnaire or Expanded Prostate
Cancer Index Composite or PC-QoL or Prostate Cancer Quality of Life scale or PROSQOLI or Prostate Cancer Specific Quality of
Life Instrument or QOLM-P14 or Quality of Life Module Prostate 14 or UCLA-PCI or UCLA Prostate Cancer Index or UCLA-
PCI-SF or UCLA Prostate Cancer Index Short Form or HOIQ or Herpes Outbreak Impact Questionnaire or Herpes Symptom
Checklist or RGHQoL or Recurrent Genital Herpes Quality of Life Questionnaire or CSFQ or Changes in Sexual Functioning
Questionnaire or DISF or Derogatis Interview for Sexual Functioning or DSFI or Derogatis Sexual Functioning Inventory or FSHQ
or Florida Sexual History Questionnaire or WSFQ orWatts Sexual Function Questionnaire or (Index of Sexual Function or (RSSF or
Radiumhemmets Scale of Sexual Functioning) or Urogenital Distress Inventory or Prostate Outcomes Questionnaire or (PORPUS or
Patient-oriented prostate utility scale) or Genital HerpesMeasure or (MMAP orMaine Medical Assessment Program symptom index)
)) or (FIM instrument or pasi or Patient-Specific Index or SAT-16 or WeeFIM or WeeFIM instrument or worc or Western Ontario
Rotator Cuff index or wosi or Western Ontario Shoulder Instability Index or 10-item Implantable Cardioverter Defibrillator Quality
of Life Questionnaire or AcroQoL or Acromegaly Quality of Life questionnaire or Oxford Hip Score or AIMS2 or Arthritis Impact
Measurement Scales or ASQoL or Ankylosing Spondylitis Quality of Life Questionnaire or BASDAI or Bath Ankylosing Spondylitis
Disease Activity Index or BASFI or Bath Ankylosing Spondylitis Functional Index or CHAQ or Childhood Health Assessment
Questionnaire or Foot Function Index or JAQQ or Juvenile Arthritis Quality of Life Questionnaire or MACTAR or McMaster
Toronto Arthritis Patient Preference Disability Questionnaire or Oxford Elbow Score or Oxford Hip Score or Oxford Shoulder Score
or PSAQoL or Psoriatic Arthritis Quality of Life Instrument or QOL-RA or Quality of Life-Rheumatoid Arthritis Scale or RAQoL
or Rheumatoid Arthritis Quality of Life Questionnaire or lsia or Life Satisfaction Index for Adolescents or Fibromyalgia Impact
Questionnaire or fiqr or Revised Fibromyalgia Impact Questionnaire or Fibromyalgia Rapid Screening Tool or mapt or (Hip and
Knee Questionnaire) or INQoL or Individualized Neuromuscular Quality of Life Questionnaire or Foot Function Index or Patient-
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Specific Index or SAT-16 or OsteoARthritis Treatment Satisfaction Questionnaire or auscan or Australian Canadian Osteoarthritis
Hand Index or koos or (Knee Injury and Osteoarthritis Outcome Score) or womac or (Western Ontario and McMaster Universities
Arthritis Index) or woos or Western Ontario Osteoarthritis of the Shoulder index or ecos-16 or Short Osteoporosis Quality of Life
Questionnaire or ofdq or Osteoporosis Functional Disability Questionnaire or opaq or Osteoporosis Assessment Questionnaire or
OPTQoL or Osteoporosis Targeted Quality of Life Questionnaire or Qualeffo-41 or (International Ostoporosis Foundation and
Quality of Life questionnaire) or qualiost or QUAlity of Life questionnaire In OSTeoporosis or Brace Questionnaire or (Keitel
Functional Assessment or Simple Shoulder Test or Rheumatology Attitudes Index or (SPADI or (Shoulder Pain and Disability Index)
) or Osteoarthritis Pain Assessment or (MHAQ or Modified Health Assessment Questionnaire) or (MSOK or Patient-based Measure
of the Severity of Osteoarthritis of the Knee) or (SAJC or Self-Administered Joint Count) or (THAOEQ or Total Hip Arthoplasty
Outcome Evaluation Questionnaire) or (MRFA or Medical Rehabilitation Follow Along) or (PPDQ or Patient Preference Disability
Questionnaire) or (Disabilities of the Arm, Shoulder, and Hand questionnaire) or Musculoskeletal Function Assessment instrument
or (OQLQ or Osteoporosis Quality of Life questionnaire) or Harris Hip Score)) or (aqel or Assessment of Quality of life at the End
of Life or artq or Attitudes to Randomised Clinical Trials Questionnaire or Brief Fatigue Inventory or Body Image Scale or Brief
Pain Diary for ambulatory patients with advanced cancer or Care Notebook or Cancer Rehabilitation Evaluation System or casc
or Comprehensive Assessment of Satisfaction with Care or cpns or Cancer Patient Need Survey or CQOLC or Caregiver Quality
of Life Index-Cancer or crfds or Cancer-Related Fatigue Distress Scale or ctsq or Cancer Therapy Satisfaction Questionnaire or
Eastern Cooperative Oncology Group performance status scale or ECOG Performance Status or EORTC QLQ-C30 or QLQ-C30
or (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Core Questionnaire) or ESAS-r
or Edmonton Symptom Assessment System Revised or FACIT or Functional Assessment of Chronic Illness Therapy Measurement
System or FLIC or Functional Living Index Cancer or flie or Functional Living Index - Emesis or givio or Interdisciplinary Group
for Cancer Care Evaluation questionnaire or glq-8 or hqli or Hospice Quality of Life Index or Illness Distress Scale or Karnofsky
Performance Status or lasa-s or Linear Analogue Self-Assessment-Selby or Mental Adjustment to Cancer Scale or mane or (Morrow
Assessment of Nausea and Emesis) or mdasi or MD Anderson Symptom Inventory or mmql or Minneapolis-Manchester Quality of
Life instrument or mpac or Memorial Pain Assessment Card or MPQOL or Miami Pediatric Quality of Life Questionnaire Parent
Scale or msas or Memorial Symptom Assessment Scale or NA-ACP or Needs Assessment for Advanced Cancer Patients or Needs
Evaluation Questionnaire or Needs at the End-of-Life Screening Tool or (Osoba Nausea and Vomiting Module) or Palliative Care
Assessment or pacis or Perceived Adjustment to Chronic Illness Scale or Psychological Distress Inventory or PedsQL Cancer Module
or Pediatric Quality of Life Inventory Cancer Module or pnat or Patient Needs Assessment Tool or QOL-CA or Quality of Life
Cancer Scale or QOL-RTI or Quality of Life Radiation Therapy Instrument or qq-q or Quality-Quantity questionnaire or qual-e or
Quality of Life at the End of Life Measure or rscl or Rotterdam Symptom Checklist or SCFS-6 or Schwartz Cancer Fatigue Scale
or Subjective Chemotherapy Impact scale or scns or Structural-Functional Social Support Scale or Therapy Impact Questionnaire or
Breast Cancer ChemotherapyQuestionnaire or IBCSG-QLC or International Breast Cancer StudyGroup -Quality of Life Core Form
or REPERES-60 or Subjective Health Estimations or gsrs or Gastrointestinal Symptom Rating Scale or QLI-CP or Quality of Life
Index for Colostomy Patients or UFS-QOL or (Uterine Fibroid Symptom and Quality of Life questionnaire) or Expanded Prostate
Cancer Index Composite or PC-QoL or Prostate Cancer Quality of Life scale or PROSQOLI or Prostate Cancer Specific Quality of
Life Instrument or QOLM-P14 or Quality of Life Module - Prostate 14 or UCLA-PCI or UCLA Prostate Cancer Index or UCLA-
PCI-SF or UCLA Prostate Cancer Index Short Form or EORTC QLQ-H&N35 or QLQ-H&N35 or (European Organization for
Research and Treatment of Cancer Quality of life - Head and Neck Cancer Module) or HNQOL or (Head and Neck Quality of
Life instrument) or LORQv3 or Liverpool Oral Rehabilitation Questionnaire or LPSQ or Liverpool-PEG-Specific Questionnaire or
ndii or Neck Dissection Impairement Index or UW-QOL or University of Washington Quality of Life Instruments or Xerostomia-
specific Questionnaire or EORTC QLQ-LC13 or QLQ-LC13 or (European Organization for Research and Treatment of Cancer
Quality of Life Questionnaire - Lung Cancer Module) or lcss or Lung Cancer Symptom Scale or Norfolk QOL-NET or Norfolk
Quality of Life - Neuroendocrine Tumor Questionnaire or Neuroendocrine Tumor Questionnaire or EORTCQLQ-OV28 or QLQ-
OV28 or (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Ovarian Cancer Module) or
EORTCQLQ-CX24 or QLQ-CX24 or (EuropeanOrganization for Research and Treatment of Cancer Quality of Life Questionnaire
- Cervical Cancer Module) or (Edmonton Staging System or (PMH PSQ-MD or Princess Margaret Hospital Patient Satisfaction
with Doctor Questionnaire) or (PPSC or Play-Performance Scale for Children) or Comprehensive questionnaire for assessing cancer
patients’ Perception of the Quality of Care or (RDCQ or Reaction to the Diagnosis of Cancer Questionnaire) or Family Pain
Questionnaire or (S-PEC or St Gallen Pain Evolution Chart) or (RSSF or Radiumhemmets Scale of Sexual Functioning) or (EFAT or
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Edmonton Functional Assessment Tool) or ((EORTCQLQ-BR23 or European Organization for Research) and Treatment of Cancer
Quality of Life Questionnaire - Breast Cancer Module) or QLQ-BR23 or (HNRQ or (Head and Neck Radiotherapy Questionnaire)
) or (HRCA-QL or Hebrew Rehabilitation Centre for the Aged Quality of Life) or Life Ingredient Profile or (OTTAT or Oncology
Treatment Toxicity Assessment Tool) or Psychological Distress Inventory or (PEDQOL or Self-rating QoL questionnaire for children
or Self-rating quality of life questionnaire for children) or (PSHN or (Performance Status scale for Head and Neck cancer patients))
or Psychosocial Summary Scale or (PSS-HN or (Performance Status Scale for Head and Neck)) or (QDDC or Qualitator Daily Diary
Card) or (QLILC or Quality of Life Inoperable Lung Cancer questionnaire) or (QLI-P or Quality of Life Index Padilla) or (Quality
of Life Index and Padilla) or (QLI-RT or Quality of Life Index-Radiation Therapy) or (QLQ-C30 or Quality of Life Questionnaire
Core 30 Items) or (QOL-ACD or Quality of Life questionnaire for cancer patients treated with Anticancer Drugs) or (QOL-CS
or Quality of Life-Cancer Survivors) or (RMH-PO or Royal Marsden Hospital Paediatric Oncology quality of life questionnaire)
or (SBI-15R or Systems of Belief Inventory) or Surviving Cancer Profile or (SELT or Skalen zur Erfassung von Lebensqualitat bei
Tumorkranken) or (SICPA or Stanford Inventory of Cancer Patient Adjustment) or (SOGQLQ or Southwest Oncology Group
Quality of Life Questionnaire) or University of Liverpool Questionnaire or (WICQP or (Wright Impact of Cancer Questionnaire and
Parents)) or Food Frequency Questionnaire or (MCPQ or Mayo Clinic Postlaryngectomy Questionnaire))) or (Brunnstrom Recovery
Scale for Hemiplegic Voluntary Control or bupp or Burke Perceptual Profile or ccse or Cognitive Capacity Screening Examination
or mmse or Mini Mental State Examination or QUALIVEEN-30 or QUALIVEEN or sat-16 or SF-QUALIVEEN or QUALIVEEN
Short Form or ICD-QOL or Implantable Cardioverter Defibrillator Quality of Life Questionnaire or AcroQoL or Acromegaly
Quality of Life questionnaire or AAIQOL or (Activity and Affect Indicators of QOL) or ACQLI or Alzheimer’s Carer’s Quality of
Life Instrument or ADCPQ or Alzheimer’s Disease Caregiver Preference Questionnaire or ADRQL or Alzheimer’s Disease-Related
Quality of Life or Apathy Inventory or Clinical Dementia Rating or cerad or Consortium to Establish a Registry for Alzheimer’s
Disease Neuropsychological Assessment Battery or Disability Assessment for Dementia or DMS48 or MM-CGI or Marwit Meuser
Caregiver Grief Inventory or Neuropsychological Test Battery or QOL-AD or Quality of Life in Alzheimer’s Disease or QUALID or
Quality of Life in Late-Stage Dementia Scale or ALSAQ or Amyotrophic Lateral Sclerosis Assessment Scales or Oxford Knee Score
or SAQOL-39 or (Stroke and Aphasia Quality of Life Scale) or Aberdeen Back Pain Scale or abps or ofdq or Oswestry Disability
Index or Osteoporosis Functional Disability Questionnaire or Psychosocial Functioning Questionnaire for Patients with Low Back
Pain or rmdq or Roland-Morris Disability Questionnaire or mcas or Modified Caregiver Appraisal Scale or BCTSQ or (Brigham and
Women’s Hospital Carpal Tunnel Syndrome Questionnaire) or adas-cog or Alzheimer’s Disease Assessment Scale, Cognitive part or
Cornell-Brown Scale for Quality of Life in Dementia or d-qol or Dementia Quality of Life Instrument or DEMQOL orMeasurement
of health-related quality of life for people with dementia or Memory Impairment Screen or Neuropsychiatric Inventory or QOLAS
or Quality of Life Assessment Schedule or Zarit Burden Interview or lsia or Life Satisfaction Index for Adolescents or CDIP-58 or
Cervical Dystonia Impact Profile or esi-55 or Epilepsy Surgery Inventory or Glasgow Epilepsy Outcome Scale or Impact of Child
Illness scale or (Katz Adjustment Scale and Epilepsy) or lsss or Liverpool Seizure Severity Scale or newqol or Quality of Life in Newly
Diagnosed Epilepsy measure or Quality of Life in Newly Diagnosed Epilepsy or qolas or Quality of Life Assessment Schedule or
QOLCE or Quality of Life in Childhood Epilepsy Questionnaire or QOLIE-10 or Quality of Life in Epilepsy Inventory-10 or
QOLIE-31 or Quality of Life in Epilepsy Inventory-31 or QOLIE-89 or Quality of Life in Epilepsy Inventory-89 or QOLIE-AD-
48 or Quality of Life in Epilepsy Inventory-Adolescents-48 or Fibromyalgia Impact Questionnaire or fiqr or Revised Fibromyalgia
Impact Questionnaire or Fibromyalgia Rapid Screening Tool or Frontal Assessment Battery or GHABP or Glasgow Hearing Aid
Benefit Profile or hana or Headache Needs Assessment questionnaire or Migraine Disability Assessment or MSQ Version 2 1 or
Migraine-SpecificQuality-of-LifeQuestionnaire orMSQoLorMigraine-SpecificQuality-of-LifeQuestionnaire or ulfi orUpper Limb
Functional Index or edss or Expanded Disability Status Scale or HAQUAMS or Hamburg Quality of Life Questionnaire Multiple
Sclerosis or MSIS-29 or Multiple Sclerosis Impact Scale or MSQLI or Multiple Sclerosis Quality of Life Inventory or MSQOL-
54 or Multiple Sclerosis Quality of Life-54 or MSWS-12 or Multiple Sclerosis Walking Scale or PS-MS or Performance Scales for
Multiple Sclerosis or Qual-OT or Quality of Life in Occupational Therapy or SI-MS or Symptom Inventory for Multiple Sclerosis
or INQoL or Individualized Neuromuscular Quality of Life Questionnaire or Myasthenia Gravis Questionnaire or Neck Disability
Index or Norfolk QOL-NET or Norfolk Quality of Life - Neuroendocrine Tumor Questionnaire or abps or Aberdeen Back Pain
Scale or Brief Pain Inventory or Neuropathic Pain 4 Questions or Integrated Pain Score or lanss or (Leeds Assessment of Neuropathic
Symptoms and Signs Pain Scale) or mpac or Memorial Pain Assessment Card or McGill Pain Questionnaire or Neuropathic Pain
Scale or npsi or Neuropathic Pain Symptom Inventory or ofdq or Osteoporosis Functional Disability Questionnaire or pqas or Pain
Quality Assessment Scale or pqas-r or Revised Pain Quality Assessment Scale or seq pain or Standard Evaluation Questionnaire on
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Pain or SF-MPQ-2 or Short-form McGill Pain Questionnaire or sopa or Survey of Pain Attitudes or Treatment Outcomes in Pain
Survey or WHYMPI or West Haven - Yale Multidimensional Pain Inventory or Wong-Baker FACES or Wong-Baker FACES Pain
Rating Scale or PDQ-39 or Parkinson’s Disease Questionnaire or PDQL or Parkinson’s Disease Quality of Life Questionnaire or
PDQUALIF or Parkinson’s Disease Quality of Life Scale or PDSS-2 or Parkinson’s Disease Sleep Scale 2 or Parkinson’s Impact Scale
or (pims and parkinson) or SCOPA-COG or SCOPA-SLEEP or Scales for Outcomes in Parkinson’s Disease or (Schwab and England
Activities of Daily Living scale) or asrs or Augmentation Severity Rating Scale or irls or International Restless Legs Syndrome Study
Group Rating Scale or P-RLS-SS or Pediatric Restless Legs Syndrome Severity Scale or RLS-QoL or Restless Legs Quality of Life
Scale or Hopkins RLS QoL or Hopkins RLS Quality of Life Scale or Epworth Sleepiness Scale or fosq or Functional Outcomes of
Sleep Questionnaire or jseq or Jenkins Sleep Evaluation Questionnaire or lseq or Leeds Sleep Evaluation Questionnaire or psqi or
Pittsburgh Sleep Quality Index or saqli or Sleep Apnea Quality of Life Index or Neurogenic Bowel Dysfunction score or Qual-OT
or Quality of Life in Occupational Therapy or QUALIVEEN or Canadian Neurological Scale or mrs-si or Structured Interview for
the Modified Rankin Scale or NEWSQOL or Newcastle Stroke-specific Quality of Life measure or nihss or National Institutes of
Health Stroke Scale or SAQOL-39 or (Stroke and Aphasia Quality of Life Scale) or Stroke Impact Scale & Stroke Toolbox or ss-
qol or Stroke-Specific Quality Of Life measure or Dizziness Handicap Inventory or UCLA-DQ or UCLA Dizziness Questionnaire
or Vertigo Handicap Questionnaire or Vertigo Symptom Scale or Voice Handicap Index or (Frenchay Activities Index or (R-ADL
or Rivermead ADL Scale) or (SA-SIP30 or Stroke Adapted 30-item SIP version) or (OSAPOSI or Obstructive Sleep Apnea Patient-
Oriented Severity Index) or Glasgow Outcome Scale or Glasgow-Pittsburgh Scale or Minor Symptom Evaluation or Dallas Pain
Questionnaire or Heat Beam Dolorimeter or (HHPPAI or Home Hospice Patient Pain Assessment Instrument) or (IPAT or Initial
Pain Assessment Tool) or (ISCRG or Illness Self Concept Repertory Grid) or (LBPRS or Low Back Pain Rating Scale) or (MMPAP
or Multiperspective Multidimensional Pain Assessment Protocol) or Pain Assessment questionnaire or Pain Assessment Index or
(PATC or Pain Assessment Tool for Children) or Pain Catastrophizing Scale or Pain Disability index or (PDS-2 or Pain Distress
Scales) or (PD-SLBP or Pain Drawing in Subacute Low Back Pain) or Pain-O-Meter or (PPAT or Pediatric Pain Assessment Tool)
or (QBPS or Quebec Back Pain Scale) or Rivermead Post-traumatic Amnesia Protocol or Rivermead Post-concussion symptoms
Questionnaire or (SPE-PC or Subjective Pain Evaluation - Pre-school Children) or SPE-PC or Global Deterioration or Progressive
Deterioration Scale or Disability Rating scale or (FGSCI or Frankel Grade for Spinal Cord Injury) or Glasgow Coma Scale or
Hunt-Hess Classification of SAH or Headache Impact Test or ((HRQOL-CE or Health-related Quality of Life) and specifically
for children with epilepsy) or (HRQOL-MS or Health-related Quality of Life questionnaire for patients with multiple sclerosis) or
Minimal Record of Disability or MS Self-Efficacy Scale or Perceived Handicap Questionnaire or (QLPSD or Quality of Life Profile
for Spine Deformities) or Rankin Scale or (Side Effects and Life Satisfaction) or (SI-PS-MS or Symptom Inventory & Performance
Scale measures for Multiple Sclerosis) or (UPDRS or Unified Parkinson’s Disease Rating Scale Awakenings) or (WPSI or Washington
Psychosocial Seizure Inventory) or (RDSQ or Rivermead Disability Status Questionnaire) or (SPADI or (Shoulder Pain and Disability
Index)) or Osteoarthritis Pain Assessment or Family Pain Questionnaire or (S-PEC or St Gallen Pain Evolution Chart) or Modified
Post-Sleep Inventory or Sleep Dysfunction scale or Numerical Rating Scale or (QLH-Y or Quality of Life Headache in Youth) or
(MBPC or (Memory and Behavior Problems Checklist)) or Mental Status Questionnaire or (PMSQ or Short Portable Mental Status
Questionnaire) or (SCAG or Sandoz Clinical Assessment Geriatric) or Subjective Stress scale or Rheumatology Attitudes Index)) or
(Oxford Hip Score or Celiac Disease Questionnaire or ADDQoL or Audit of Diabetes Dependent QoL or Appraisal of Diabetes
Scale or D-FISQ or (Diabetes Fear of Injecting and Self-testing Questionnaire) or das-3 or Diabetes Attitude Scale or Diabetes Care
Profile or Diabetes Clinic Satisfaction Questionnaire or Diabetes Empowerment Scale or dfbs or Diabetes Family Behavior Scale or
Diabetic Foot Ulcer Scale or DHP-1 or DHP-18 or Diabetes Health Profile or DiabMedSat or Diabetes Medication Satisfaction or
dims or Diabetes Impact Measurement Scales or Diabetes Knowledge Questionnaire or Diabetes Knowledge Test or Diabetes Mellitus
History or Diabetes Productivity Measure or DQLCTQ or Diabetes Quality of Life Clinical Trial Questionnaire or dqol or Diabetes
Quality of Life measure or dqoly or Diabetes Quality of Life for Youth scale or dsc-r or Diabetes Symptom Measure or (DSMP or
DSMP-F) or Diabetes Self-Management Profile or DSQOLS or Diabetes specific quality of life scale or DTSQ-for-FIT20 Change or
DTSQ-for-FIT20 Status or dtsq or Functional Insulin Treatment Satisfaction Questionnaire or dtsqs or dtsqc or Diabetes Treatment
Satisfaction Questionnaire or Hypoglycemia Fear Survey or Impact of Child Illness scale or itsq or Insulin Treatment Satisfaction
Questionnaire or Multidimensional Diabetes Questionnaire or mnsi or Michigan Neuropathy Screening Instrument or Norfolk
QOL-DN or Norfolk Quality of Life Questionnaire - Diabetic Neuropathy or Problem Areas in Diabetes scale or PedsQL Diabetes
Module or Pediatric Quality of Life Inventory Diabetes Module or psit or Patient Satisfaction with Insulin Therapy questionnaire
or Studying the Hurdles of Insulin Prescription or w-bq or Well-Being Questionnaire or we-care or (WEll-being and Satisfaction
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of CAREgivers of Children with Diabetes Questionnaire) or debq or Dutch Eating Behavior Questionnaire or IWQOL-Kids or
Impact of Weight on Quality of Life - Kids or IWQOL-Lite or Impact of Weight on Quality of Life - Lite or OWLQOL or
(Obesity and Weight-Loss Quality of Life measure) or WRSM or Weight-Related Symptom Measure or (ORWELL 97 or Obesity
Related Well-Being or (QLDUP or Quality of Life in Duodenal Ulcer Patients))) or (AdolRQLQ or Adolescent Rhinoconjunctivitis
Quality of Life Questionnaire or MiniRQLQ or Mini Rhinoconjunctivitis Quality of Life Questionnaire or NRQLQ or Nocturnal
Rhinoconjunctivitis Quality of Life Questionnaire or PRQLQ or Paediatric Rhinoconjunctivitis Quality of Life Questionnaire or
RQLQ or Rhinoconjunctivitis Quality of Life Questionnaire or GHABP or Glasgow Hearing Aid Benefit Profile or PAR-ENT-QoL
or (effects of Rhinopharyngitis and otitis of the child upon family life) or RhinQLQ or Rhinitis Quality of Life Questionnaire or
rsdi or Rhinosinusitis Disability Index or rsui or Rhinitis Symptom Utility Index or Dizziness Handicap Inventory or UCLA-DQ or
UCLA Dizziness Questionnaire or Vertigo Handicap Questionnaire or Vertigo Symptom Scale or Voice Handicap Index or (MCPQ
or Mayo Clinic Postlaryngectomy Questionnaire or (PQLQ or Paediatric Quality of Life Questionnaire) or (MD POSI or Meniere’s
Disease Patient-Oriented Severity Index) or (OM-CSI or Otitis Media Clinical Severity Index) or Otitis Media Diary or (OM-FSQ
or Otitis Media Functional Status Questionnaire) or (UPSIT or University of Pennsylvania Smell Identification Test) or (Vertigo,
Dizziness and Imbalance questionnaire) or Hearing Coping Assessment)) or (Kingsley Alopecia Profile or SAQOL-39 or (Stroke
and Aphasia Quality of Life Scale) or 8-item ICD-QOL or 8-item Implantable Cardioverter Defibrillator-specific Quality of Life
Questionnaire or PACT-Q or Perception of Anticoagulant Treatment Questionnaire or abps or Aberdeen Back Pain Scale or Oswestry
Disability Index or ofdq or Osteoporosis Functional Disability Questionnaire or Psychosocial Functioning Questionnaire for Patients
with Low Back Pain or rmdq or Roland-Morris Disability Questionnaire or FACIT or Functional Assessment of Chronic Illness
Therapy Measurement System or heiq or Health Education Impact Questionnaire or Constipation Assessment Scale or Neurogenic
Bowel Dysfunction score or pac-qol or Patient Assessment of Constipation Quality of Life questionnaire or pac-sym or Patient
Assessment of Constipation Symptoms or cqlq or Cough Quality of Life Questionnaire or CDIP-58 or Cervical Dystonia Impact
Profile or Aberdeen Dyspepsia Questionnaire or dsiq or (Digestive Symptoms and Impact Questionnaire) or FDDQL or Quality
of Life Questionnaire for Functional Digestive Disorders or GSRS-self or Gastrointestinal Symptom Rating Scale self-administered
version or Leeds Dyspepsia Questionnaire or ndi-sf or Nepean Dyspepsia Index or PAGI-QOL or Patient Assessment of Upper
Gastrointestinal Disorders-Quality of Life or PAGI-SYM or Patient Assessment of Gastrointestinal Disorders Symptom Severity
Index or QOLRAD or (Quality Of Life in Reflux and Dyspepsia) or qpd-32 or Questionnaire for Peptic Disease-32 items or Severity
of Dyspepsia Assessment or Brief Fatigue Inventory or crfds or Cancer-Related Fatigue Distress Scale or D-FISQ or Daily Fatigue
Impact Scale or defs or Dutch Exertion Fatigue Scale or dufs or Dutch Fatigue Scale or Fatigue Impact Scale or Fatigue Symptom
Inventory or Fatigue Severity Scale or Iowa Fatigue Scale or vas-f or Lee Fatigue Scale or Multidimensional Assessment of Fatigue
or Multidimensional Fatigue Inventory or mfis or Modified Fatigue Impact Scale or mfsi or Multidimensional Fatigue Symptom
Inventory or SCFS-6 or Schwartz Cancer Fatigue Scale or gcsi or Gastroparesis Cardinal Symptom Index or PAGI-QOL or Patient
Assessment of Upper Gastrointestinal Disorders-Quality of Life or PAGI-SYM or Patient Assessment of Gastrointestinal Disorders
SymptomSeverity Index orGHABPorGlasgowHearingAidBenefit Profile orMenorrhagiaOutcomesQuestionnaire orMenorrhagia
Questionnaire or Menstrual Distress Questionnaire or (inv-2 or invr) or (Rhodes Index of Nausea and Vomiting-FORM 2) or (Index
of Nausea, Vomiting, and Retching) or mane or (Morrow Assessment of Nausea and Emesis) or Nausea Questionnaire or Neck
Disability Index or debq or Dutch Eating Behavior Questionnaire or IWQOL-Kids or Impact of Weight on Quality of Life - Kids
or IWQOL-Lite or Impact of Weight on Quality of Life - Lite or OWLQOL or (Obesity and Weight-Loss Quality of Life measure)
or wrsm or Weight-Related Symptom Measure or abps or Aberdeen Back Pain Scale or Brief Pain Inventory or Neuropathic Pain 4
Questions or hana orHeadacheNeeds Assessment questionnaire or Integrated Pain Score or lanss or (Leeds Assessment of Neuropathic
Symptoms and Signs Pain Scale) or mpac or Memorial Pain Assessment Card or McGill Pain Questionnaire or npsi or Neuropathic
Pain Scale or Neuropathic Pain Symptom Inventory or OFDQ or Osteoporosis Functional Disability Questionnaire or pqas or Pain
Quality Assessment Scale or pqas-r or Revised Pain Quality Assessment Scale or seq pain or Standard Evaluation Questionnaire on
Pain or SF-MPQ-2 or Short-form McGill Pain Questionnaire or sopa or Survey of Pain Attitudes or Treatment Outcomes in Pain
Survey or WHYMPI or West Haven - Yale Multidimensional Pain Inventory or Wong-Baker FACES or Wong-Baker FACES Pain
Rating Scale or Epworth Sleepiness Scale or fosq or Functional Outcomes of Sleep Questionnaire or jseq or Jenkins Sleep Evaluation
Questionnaire or lseq or Leeds Sleep Evaluation Questionnaire or psqi or Pittsburgh Sleep Quality Index or saqli or Sleep Apnea
Quality of Life Index or OAB-q or (Overactive Bladder symptom and health-related quality of life questionnaire) or contilife or
Quality of Life Assessment Questionnaire Concerning Urinary Incontinence or Detrusor Instability Score or I-QOL or Urinary
Incontinence-Specific Quality of Life Instrument or ICIQ-FLUTS or International Consultation on Incontinence Questionnaire-
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Female Lower Urinary Tract Symptoms or ICIQ-UI Short Form or International Consultation on Incontinence Questionnaire -
Urinary Incontinence Short Form or Incontinence Stress Index or King’s Health Questionnaire or mudi or Male Urogenital Distress
Inventory or musiq or Male Urinary Symptom Impact Questionnaire or n-qol or Nocturia Quality of Life Questionnaire or pmses
or Broome Pelvic Muscle Exercise Self-Efficacy Scale or (Symptom Severity Index for stress incontinence in women or Symptom
Impact Index for stress incontinence in women) or uihi or Urinary Incontinence Handicap Inventory or Urinary Symptom Profile or
yips or York Incontinence Perceptions Scale or Dizziness Handicap Inventory or UCLA-DQ or UCLA Dizziness Questionnaire or
Vertigo Handicap Questionnaire or Vertigo Symptom Scale or Voice Handicap Index or (MPSI or Modified Post-Sleep Inventory or
Sleep Dysfunction scale or Numerical Rating Scale or (QLH-Y or Quality of Life Headache in Youth) or Hearing Coping Assessment
or Qualite de Vie et Migraine or Rivermead Head Injury follow-up questionnaire or (SRFS or Self-Rating Fatigue Scale) or (V-
RQOL or Voice-related quality of life) or (WHeadQ or Waters Headache Questionnaire) or (ORWELL 97 or Obesity Related Well-
Being) or Fatigue Impact Scale or (HCIQ or Health Consequences of Injury Questionnaire) or (OSAPOSI or Obstructive Sleep
Apnea Patient-Oriented Severity Index) or Dallas Pain Questionnaire or Heat Beam Dolorimeter or (HHPPAI or Home Hospice
Patient Pain Assessment Instrument) or (IPAT or Initial Pain Assessment Tool) or (ISCRG or Illness Self Concept Repertory Grid)
or (LBPRS or Low Back Pain Rating Scale) or (MMPAP or Multiperspective Multidimensional Pain Assessment Protocol) or Pain
Assessment questionnaire or Pain Assessment Index or (PATC or Pain Assessment Tool for Children) or Pain Catastrophizing Scale or
Pain Disability index or (PDS-2 or Pain Distress Scales) or (PD-SLBP or Pain Drawing in Subacute Low Back Pain) or Pain-O-Meter
or (PPAT or Pediatric Pain Assessment Tool) or (QBPS or Quebec Back Pain Scale) or Rivermead Post-traumatic Amnesia Protocol
or (SPE-PC or Subjective Pain Evaluation - Pre-school Children) or (Oral Functioning Scale and Kiyak) or (SPADI or (Shoulder
Pain and Disability Index)) or Osteoarthritis Pain Assessment or Frenchay Activities Index or (R-ADL or Rivermead ADL Scale) or
(SA-SIP30 or Stroke Adapted 30-item SIP version) or Family Pain Questionnaire or (S-PEC or St Gallen Pain Evolution Chart))
) or (4DSQ or Four-Dimensional Symptom Questionnaire or basis-24 or (Revised Behavior and Symptom Identification Scale) or
BASIS-32 or (Behavior and Symptom Identification Scale) or BPRS or Brief Psychiatric Rating Scale or Brief Symptom Inventory
or (Camberwell Assessment of Need for adults with Developmental and Intellectual Disabilities) or (Comprehensive Assessment
and Referral Evaluation) or CES-D or Center for Epidemiologic Studies Depression Scale or EWPS or Endicott Work Productivity
Scale or Global Assessment Scale or General Health Questionnaire or GSDS-II or Groningen Social Disabilities Schedule or General
Satisfaction Questionnaire or MAACL-R or Multiple Affect Adjective Checklist-Revised or Mayers’ LSQ 1 or Mayers’ LSQ 2 or
(Mayers’ Lifestyle Questionnaire 1 or Mayers’ Lifestyle Questionnaire 2) or mmse or Mini Mental State Examination or PAIS-SR or
Psychosocial Adjustment to Illness Scale or Piers-Harris 2 or Piers-Harris Children’s Self-Concept Scale Second Edition or Piers-Harris
Children’s Self-Concept Scale or Profile of Mood States or POMS or POMS-bi or Profile of Mood States Bipolar Scale or PRIME-
MD PHQ or Primary Care Evaluation ofMental Disorders Patient HealthQuestionnaire or PSYCHLOPS or Psychological Outcome
Profiles or PTQL or Pictorial Thai Quality of Life or Q-LES-Q or (Quality of Life Enjoyment and Satisfaction Questionnaire) or
(QLQ-IR or QLQ-SR) or Oregon Quality of Life Questionnaire Interviewer Rating version or Oregon Quality of Life Questionnaire
Interviewer Respondent Self-Report version or Oregon Quality of Life Questionnaire or QPD Panel or Quick PsychoDiagnostics
Panel or RBMT or Rivermead Behavioral Memory Test or Social Behaviour Schedule or SCL-90-R or SymptomChecklist-90-Revised
or Social Functioning Schedule or SOS-10 or Schwartz Outcome Scale-10 or VABS or Vineland Adaptive Behaviour Scales or W-QLI
or Wisconsin Quality of Life Index or AAIQOL or (Activity and Affect Indicators of QOL) or ACQLI or Alzheimer’s Carer’s Quality
of Life Instrument or ADCPQ or Alzheimer’s Disease-Related Quality of Life or Apathy Inventory or Clinical Dementia Rating
or cerad or Consortium to Establish a Registry for Alzheimer’s Disease - Neuropsychological Assessment Battery or Consortium to
Establish a Registry for Alzheimer’s Disease - Clinical Assessment Battery or Disability Assessment for Dementia or DMS48 or MM-
CGI or Marwit Meuser Caregiver Grief Inventory or Neuropsychological Test Battery or QOL-AD or Quality of Life in Alzheimer’s
Disease or QUALID or Quality of Life in Late-Stage Dementia Scale or CMDQ or Common Mental Disorder Questionnaire or
DUKE-AD or Duke Anxiety - Depression Scale or HADS or (Hospital Anxiety and Depression scale) or HAM-A or Hamilton
Anxiety Scale or LSAS or Liebowitz Social Anxiety Scale or (Panic and Agoraphobia Scale) or STAI or State-Trait Anxiety Inventory
or SWAM scale or Satisfaction With Antipsychotic Medication scale or Body Image Scale or DAS24 or Derriford Appearance Scale -
Short form or DAS59 or Derriford Appearance Scale or YQOL-FD or Youth Quality of Life Instrument - Facial differences Module
or ADAS-COG or Alzheimer’s Disease Assessment Scale, Cognitive part or Cornell-Brown Scale for Quality of Life in Dementia or d-
qol or Dementia Quality of Life Instrument or DEMQOL or Measurement of health-related quality of life for people with dementia
or Memory Impairment Screen or Neuropsychiatric Inventory or QOLAS or Quality of Life Assessment Schedule or Zarit Burden
Interview or BeckDepression Inventory or Carroll Rating Scale for Depression or Geriatric Depression Scale or Hamilton Depression
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Rating Scale or Harvard Department of Psychiatry-NDSD scale or (IDS-SR or IDS-C) or Inventory of Depressive Symptomatology
or MADRS or Montgomery-Asberg Depression Rating Scale or Major Depression Inventory or (QIDS-SR or QIDS-C) or Quick
Inventory of Depressive Symptomatology or QLDS or Quality of Life in Depression Scale or Rand 8-item Depression Screener or
Short Depression Interview or SDSS or Signs of Depression Screening Scale or debq or Dutch Eating Behavior Questionnaire or
EDI-3 or Eating Disorder Inventory or BSFQ or Brief Sexual Function Questionnaire or CMSH-SFQ or (Center for Marital and
Sexual Health Sexual Functioning Questionnaire) or Erectile Dysfunction Inventory of Treatment Satisfaction or FSHQ or Florida
Sexual History Questionnaire or iief-5 or International Index of Erectile Function or Index of Sexual Life or MSHQ or Male Sexual
Health Questionnaire or (Self-Esteem and Relationship Questionnaire) or Sexual Function Index or SLQQ or Sexual Life Quality
Questionnaire or Profile of Female Sexual Function or Camberwell Assessment of Need or Camberwell Assessment of Need for the
Elderly orDIS-IV orDiagnostic Interview Schedule - IV or ILSS or Independent Living Skills Survey or LQOLPor Lancashire Quality
of Life Profile or (Personal and Social Performance Scale) or (Quality of Life Questionnaire or Client Experiences Questionnaire)
or QLS-BC or Quality of Life Schedule or Research Diagnostic Criteria or Social Dysfunction Index or Social Role Performance
schedule or Threshold Assessment Grid or Treatment Attitudes in Psychiatry Scales or ASRS or Augmentation Severity Rating Scale
or irls or International Restless Legs Syndrome Study Group Rating Scale or P-RLS-SS or Pediatric Restless Legs Syndrome Severity
Scale or RLS-QoL or Hopkins RLS QoL or Restless Legs Quality of Life Scale or Hopkins RLS Quality of Life Scale or ASFQ or
(Antipsychotics and Sexual Functioning Questionnaire) or (DAI-30 or DAI-10) or Drug Attitude Inventory or NSA-16 or Negative
Symptom Assessment or Quality of Life Scale or Social Dysfunction Index or SFS2 or Social Functioning Scale or Subjects’ Response
to Antipsychotics or SatisfactionWith Antipsychotic Medication scale or SubjectiveWell-being under Neuroleptic treatment or ASEX
or Arizona Sexual Experience Scale or FSDS or Female Sexual Distress Scale or AWQV2 or AmphetamineWithdrawal Questionnaire
Version 2 or AWQV or Smoker Anchored Withdrawal Grid or Smoker Complaint Scale or STAR-SMOQ55 or Situation X Trait
Adaptative Response Smoking Motivation questionnaire or TLFB or Timeline Followback Method or CMDQ or Common Mental
Disorder Questionnaire or (TRIG or Texas Revised Inventory of Grief or (TSCS or Tennessee Self-Concept Scale) or Inventory
of Current Concerns or Impaired Control Scale or Motivational Structure Questionnaire or (NABSQ or Newcastle Adolescent
Behaviour Screening Questionnaire) or (PALS or (Perceived stress, Affect, Loneliness and Satisfaction)) or Geriatric Hopelessness
Scale or (MUNSH or Memorial University of Newfoundland Scale of Happiness) or (OAHMQ or (Older Adult Health and Mood
Questionnaire)) or (RPGMorRevised PhiladelphiaGeriatricMorale scales) or (MBPC or (Memory andBehavior ProblemsChecklist)
) or Mental Status Questionnaire or (PMSQ or Short PortableMental Status Questionnaire) or (SCAG or Sandoz Clinical Assessment
Geriatric) or Subjective Stress scale or Present State Examination or Schedules for Clinical Assessment in Neuropsychiatry or Life
Closure scale or Profile of Adaptation to Life or (SDRS or Social Dysfunction Rating Scale) or (SAHD or Schedule of Attitudes
toward Hastened Death) or (PADQ or Psychosocial Aspects of Donation Questionnaire) or (NCSE or Neurobehavioral Cognitive
Status Examination) or (RPAB or Rivermead Perceptual Assessment Battery) or Trail-Making Test or (WAIS or Wechsler Adult
Intelligence Scale) or Sense of Coherence Scale or Jalowiec Coping Scale or Multidimensional Coping Inventory or (MEPSI or
Modified Erikson Psychosocial Stage Inventory) or Parenting Stress Index or Impact of Event Scale or (RLCQ or Recent Life Changes
Questionnaire) or Schedule of Recent Experience or (Levels of Attribution and Change) or Meaning of Illness Questionnaire or
Multiple Locus of Control or (PHLOC or Parent Health Locus of Control scales) or (RIES or Revised Internal-External Scale) or
Occupational Stress Inventory or Life Orientation Test or Eysenck Personality Inventory or Karolinska Scales of Personality or (MMPI
or Minnesota Multiphasic Personality Inventory) or Maudsley Personality Inventory or Multidimensional Personality Questionnaire
or PRF-Eor Personality Research Form E or Treatment Services Review or Retirement Descriptive index or (RSES or Rosenberg’s Self-
Esteem Scale) or Self-Esteem Inventory or (SLSCL or Self-Liking Self-Competence Scale) or (ISSI or Interview Schedule for Social
Interaction) or Social Experiences Checklist or Social Problem Questionnaire or (AAIS or Adolescent Alcohol Involvement Scale)
or Addiction Admission Scale or (AASE or Alcohol Abstinence Self-Efficacy Scale) or Adolescent Diagnostic Interview or Alcohol
Dependence Scale or Alcohol Expectancy Questionnaire or (AEQ-A or Alcohol Expectancy Questionnaire-Adolescent Form) or
Addiction Potential Scale or Addiction Severity Index or (ASRPT or Alcohol-Specific Role Play Test) or (AUDADIS or “Alcohol Use
Disorders and Associated Disabilities Interview Schedule”) or “Alcohol Use Disorders Identification Test” or (BL-VAS or Bond-Lader
VAS) or (BPRPI or Brown-Peterson Recovery Progress Inventory) or CAGE Questionnaire or (CDDR or “Customary Drinking and
Drug Use Record”) or Comprehensive Drinker Profile or (CIDI core or Composite International Diagnostic Interview) or (CIWA-
AD or Clinical Institute Withdrawal Assessment) or (CLDH or Cognitive Lifetime Drinking History) or (CSDD or Cornell Scale
for Depression in Dementia) or Drinking Expectancy Questionnaire or Drinking Problems Index or (DRIE or Drinking-Related
Internal-External Locus of Control Scale) or (DrInC or Drinker Inventory of Consequences) or (DRSEQ or Drinking Refusal Self-
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Efficacy Questionnaire) or (DSML or Drinking Self-Monitoring Log) or (DUSI-R or “Drug Use Screening Inventory”) or (EPDS or
Edinburgh Postnatal Depression Scale) or Follow-up Drinker Profile or (F-SMAST or Adapted ShortMichigan Alcoholism Screening
Test for Fathers) or Family Tree Questionnaire for Assessing Family History of Alcohol Problems or (GAFS or Global Assessment
of Functioning Scale) or Geriatric Mental State or (HSCL or Hopkins Symptom Checklist) or (IDTS or Inventory of Drug-Taking
Situations) or (IPAT-A or IPAT Anxiety scale) or (IPAT-D or IPAT Depression scale) or (IQCODE or Informant Questionnaire on
Cognitive Decline in the Elderly) or MacAndrew Alcoholism Scale or (MACL orMood Adjective Check-List) or Munich Alcoholism
Test or Michigan Alcoholism Screening Test or (McSad or Utility measure for major, unipolar depression) or (MHRSD or Modified
HamiltonRating Scale forDepression) or (Mental, Physical, and Spiritual well-being scale) or (NAEQorNegative Alcohol Expectancy
Questionnaire) or Obsessive Compulsive Drinking Scale or (PANSS or (Positive and Negative Syndrome Scale for Schizophrenia)
) or (PBDS or Perceived Benefit of Drinking Scale) or (PCL-C or Post Traumatic Stress Disorders Checklist-Civilian) or Personal
Experience Inventory or Psychiatric Epidemiology Research Interview or (PESQ or Personal Experience Screening Questionnaire) or
Personal Health Survey or (PI-ED or Paediatric Index of Emotional Distress) or Purpose in Life Scale or (PIPD or Predictive Index for
Postpartum Depression) or Problem Oriented Screening Instrument for Teenagers or (PPAAUS or (Primary Prevention Awareness,
Attitude and Usage Scales)) or (Psychiatric Research Interview for Substance andMental Disorders) or (PSAS or Psychiatric Symptom
Assessment Scale) or Pediatric Symptom Checklist or Problem Situation Inventory or Index Rand Quantity Frequency or Quantity-
Frequency Methods or QLI-L or (Quality of Life Interview and Lehman) or (QMHAU or “Questionnaire Measure of Habitual
Alcohol Use”) or (RAATE or (Recovery Attitude and Treatment Evaluator)) or (RAPI or Rutgers Alcohol Problem Index) or Renard
Diagnostic Interview or Restrained Drinking Scale or (RTCQ-TV or Readiness to Change Questionnaire Treatment Version) or
(SAAST or Self-Administered Alcoholism Screening Test) or (SADD or Short Alcohol Dependence Data) or (SADQ or Severity of
Alcohol Dependence Questionnaire) or (SADS or (Schedule for Affective Disorders and Schizophrenia)) or (Survey of Activities and
fear of Falling in the Elderly) or (SAS-II or Social Adjustment Scale - II) or (SASSI or Substance Abuse Subtle Screening Inventory)
or Self-report for Childhood Anxiety Related Disorder or Situational Confidence Questionnaire or (SCQOL or Smoking Cessation
Quality of Life questionnaire) or (Stages of Change Readiness and Treatment Eagerness Scale) or Symptom Questionnaire or (SQLS
or Schizophrenia Quality of Life Scale) or (SQOLB or Sertraline Quality of Life Battery) or (SRQ-D or Self Rating Questionnaire
for Depression) or Symptom Rating Test or (SSAGA-II or Semi-Structured Assessment for the Genetics of Alcoholism) or Scale for
Suicide Ideation or (SUDDS-IV or “Substance Use Disorders Diagnostic Schedule”) or T-ACE or Toronto Alexithymia Scale or
(T-ASI or Teen-Addiction Severity Index) or (TBAQ or Toddler Behavior Assessment Questionnaire) or (Temptation and Restraint
Inventory) or (URICA or University of Rhode Island Change Assessment Scale) or Veterans Alcoholism Screening Test or Vietnamese
Depression Scale or (WSWS or Wisconsin Smoking Withdrawal Scale) or (YAAPST or Young Adult Alcohol Problems Screening
Test) or (Y-BOCS or Yale-Brown Obsessive Compulsive Scale) or Zung Depression Scale or Wechsler Memory Scale or (WMS-C or
WechslerMemory Scale - Children) or (HPPQ orHeart Patients Psychological Questionnaire) or Salience of Lifestyle Index or (SLDS
or Satisfaction with Life Domains Scale) or (MAHSC orMulti-Attribute Health Status Classification) or (RDRS-2 or Rapid Disability
Rating Scale-2) or Global Deterioration or Progressive Deterioration Scale or Index of Sexual Function or (MPSI or Modified Post-
Sleep Inventory) or SleepDysfunction scale or (TRIG or Texas Revised Inventory of Grief ) or (TSCS or Tennessee Self-Concept Scale)
)) or (Chronic Respiratory Disease Questionnaire or CRQ-SAS or Chronic Respiratory Disease Questionnaire Self-Administered
Standardized or PICQoL or Paediatric Intensive Care Quality of Life questionnaire or (Attitudes to Asthma Questionnaire or
Adolescent Asthma Quality of Life Questionnaire or AAQOL or Asthma Bother Profile or Asthma Control Diary or Asthma Control
Questionnaire or acss or Asthma Control Scoring System or Asthma Control Test or About My Asthma or aq30 or aq20 or Airways
Questionnaire or aqlq or Asthma Quality of Life Questionnaire or AQLQ-M or (Asthma Quality of Life Questionnaire and Marks)
or AQLQ-NAA or Asthma Quality of Life Questionnaire for Native American Adults or Asthma Symptom Checklist or Asthma
Self-Efficacy Scale or asui or Asthma Symptom Utility Index or Bronchial Hyperresponsiveness Questionnaire or caqs or Childhood
Asthma Questionnaires or Childhood Asthma Questionnaire or Inhaled Corticosteroid Questionnaire or KASE-AQ or (Knowledge,
Attitude and Self-efficacy Asthma Questionnaire) or LWAQ or Living with Asthma Questionnaire or MiniAQLQ or Mini Asthma
Quality of Life Questionnaire or PACQLQ or Paediatric Asthma Caregiver’s Quality of Life Questionnaire or PAQLQ or Paediatric
Asthma Quality of Life Questionnaire or QLQ-Asthma or Questionnaire for the Assessment of Quality of Life in Asthma Patients or
SGRQ or St George’s Respiratory Questionnaire) or WURSS or Wisconsin Upper Respiratory Symptom Survey or cqlq or Cough
Quality of Life Questionnaire or Cystic Fibrosis Questionnaire or IIWS or Influenza Impact Wellbeing Scale or Influenza Symptom
Severity scale or EORTCQLQ-LC13 orQLQ-LC13 or (EuropeanOrganization for Research andTreatment of CancerQuality of Life
Questionnaire - Lung Cancer Module) or LCSS or Lung Cancer Symptom Scale or CAP-Sym or Community-Acquired Pneumonia
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Symptom questionnaire or (AQ30 or AQ20) or Airways Questionnaire or BDI-TDI or (Baseline and Transition Dyspnea Indexes)
or baseline dyspnea index or Transition Dyspnea Index or Bronchial Hyperresponsiveness Questionnaire or Breathing Problems
Questionnaire or Clinical COPDQuestionnaire or Chronic Respiratory Disease Questionnaire or CRQ-SAS or Chronic Respiratory
Disease Questionnaire Self-Administered Standardized or Inhaled Corticosteroid Questionnaire or PFSDQ or Pulmonary Functional
Status & Dyspnea Questionnaire or PFSDQ-M or Pulmonary Functional Status & Dyspnea Questionnaire-modified or qual-e or
Quality of Life at the End of Life Measure or SGRQ or St George’s Respiratory Questionnaire or SOLQ or Seattle Obstructive Lung
Disease Questionnaire or PACT-Q or Perception of Anticoagulant Treatment Questionnaire or MRF26 or Maugeri Foundation
Respiratory Failure Questionnaire or AdolRQLQ or Adolescent Rhinoconjunctivitis Quality of Life Questionnaire or MiniRQLQ or
Mini Rhinoconjunctivitis Quality of Life Questionnaire or NRQLQ or Nocturnal Rhinoconjunctivitis Quality of Life Questionnaire
or PAR-ENT-QoLor (effects of Rhinopharyngitis and otitis of the child upon family life) or PRQLQor Paediatric Rhinoconjunctivitis
Quality of Life Questionnaire or RhinQLQ or Rhinitis Quality of Life Questionnaire or RQLQ or Rhinoconjunctivitis Quality of
Life Questionnaire or rsdi or Rhinosinusitis Disability Index or rsui or Rhinitis Symptom Utility Index or rsdi or Rhinosinusitis
Disability Index or Voice Handicap Index or (Satisfaction with Illness scale or (ACAAI-LQ or American College of Allergy, Asthma&
Immunology - Life Quality) or (ISAAC or (International Study of Asthma and Allergies in Childhood)) or Life Activity questionnaire
for Childhood Asthma or (LAQ-AA or Life Activities Questionnaire for Adult Asthma) or (LAQ-CA or Life Activities Questionnaire
for Childhood Asthma) or LIFE-Aor Life Activities Questionnaire for Adult Asthma or LIFE-Cor Life Activities Questionnaire for
Childhood Asthma or (PCAQ or Perceived Control of Asthma Questionnaire) or Tasmanian Asthma survey or Feinstein’s Index of
Dyspnoea or Fletcher’s Scale or Human Activity Profile Test or (MRC-D or Medical Research Council scale - Dyspnoea) or Oxygen
Cost Diagram or Pulmonary Function Status Scale or pfss or (RIQLQ or Respiratory IllnessQuality of Life Questionnaire) or (RQLQ
or Respiratory Quality of Life Questionnaire) or (VAS-D or Visual Analogue Scale - Dyspnoea) or (OSAPOSI or Obstructive Sleep
Apnea Patient-Oriented Severity Index))) or (CDLQI or Children’s Dermatology Life Quality Index or DLQI or Dermatology Life
Quality Index or DQOLS or Dermatology Quality of Life Scales or DSQL-CD or Dermatology-Specific Quality of Life instrument
for Contact Dermatitis or Dermatology-Specific Quality of Life instrument for Contact Dermatitis or FDLQI or Family Dermatology
Life Quality Index or (skindex or skindex-29 or skindex-16) or Acne Disability Index or DSQL-Acne or Dermatology-Specific
Quality of Life Instrument for Acne or Kingsley Alopecia Profile or (AIMS2 or Arthritis Impact Measurement Scales or ASQoL or
Ankylosing Spondylitis Quality of Life Questionnaire or BASDAI or Bath Ankylosing Spondylitis Disease Activity Index or BASFI or
Bath Ankylosing Spondylitis Functional Index or CHAQ or Childhood Health Assessment Questionnaire or Foot Function Index or
JAQQ or Juvenile Arthritis Quality of Life Questionnaire or MACTAR or McMaster Toronto Arthritis Patient Preference Disability
Questionnaire or Oxford Elbow Score or Oxford Hip Score or Oxford Shoulder Score or PSAQoL or Psoriatic Arthritis Quality
of Life Instrument or QOL-RA or Quality of Life-Rheumatoid Arthritis Scale or RAQoL or Rheumatoid Arthritis Quality of Life
Questionnaire) or Breast Cancer ChemotherapyQuestionnaire or IBCSG-QLC or International Breast Cancer StudyGroup -Quality
of Life Core Form or REPERES-60 or Subjective Health Estimations or PIQoL-AD or Parents’ Index of Quality of Life in Atopic
Dermatitis or QoLIAD or Quality of Life Index for Atopic Dermatitis or Dermatitis Family Impact questionnaire or IDQOL or
Infants’ Dermatitis QOL Index or Patient-Oriented Eczema Measure or CCVUQ or Charing Cross Venous Ulcer Questionnaire
or Diabetic Foot Ulcer Scale or LFUQ or (Leg and Foot Ulcer Questionnaire) or SLEQoL or Systemic Lupus Erythematosus
Quality of Life Questionnaire or Onychomycosis Quality of Life questionnaire or Psoriasis Disability Index or PQOL-12 or 12-
Item Psoriasis Quality of Life Questionnaire or PSAQoL or Psoriatic Arthritis Quality of Life Instrument or Cuestionario Especifico
en Condilomas Acuminados or (HRQOL-O or Health-related Quality of Life onychomycosis or (QLDUP or Quality of Life in
Duodenal Ulcer Patients) or (QLPO or Quality of Life of Persons with Onychomycosis) or (SLDI or Systemic Lupus International
Coordinating Committee) or (SLICC ACR or damage Index) or (SLEDAI or Systemic Lupus Erythematosus Disease Activity Index)
or Keitel Functional Assessment or Simple Shoulder Test or (MHAQ or Modified Health Assessment Questionnaire) or (MSOK
or Patient-based Measure of the Severity of Osteoarthritis of the Knee) or (SAJC or Self-Administered Joint Count))) or (CHILD-
OIDP or Child-Oral Impact on Daily Performance Index or COHQoL or Child Oral Health Quality of Life Questionnaire or
LORQv3 or Liverpool Oral Rehabilitation Questionnaire or (OHIP or OHIP-14) or Oral Health Impact Profile or OIDP or Oral
Impact on Daily Performance Index or Oral Impact on Daily Performance Index - modified version or PAR-ENT-QoL or (effects
of Rhinopharyngitis and otitis of the child upon family life) or (effects of Rhinopharyngitis or otitis of the child upon family life)
or ((Oral Functioning Scale and Kiyak) or (PoSSe or Postoperative symptom severity))) or (WISP or Well-being Index for Surgical
Patients or Ostomy Adjustment Scale or Transplant Disease Questionnaire or (PQLQ or Paediatric Quality of Life Questionnaire) or
(PoSSe or Postoperative symptom severity) or (THAOEQ or Total Hip Arthoplasty Outcome Evaluation Questionnaire) or (MCPQ
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or Mayo Clinic Postlaryngectomy Questionnaire) or (Patient-Specific Index or BREAST-Q or CROQ or Coronary Revascularisation
Outcome Questionnaire or SQLI or Stoma Quality of Life Index or Stoma-QOL or Stoma-QOL or (pasi and patient))) or (ESRD-
SCL-TM or End-Stage Renal Disease Symptom Checklist- Transplantation Module or KDQOL or Kidney Disease Quality of Life
instrument or qual-e orQuality of Life at the End of LifeMeasure orDAN-PSS-1 orDanish Prostatic SymptomScore or ICIQ-FLUTS
or International Consultation on Incontinence Questionnaire-Female Lower Urinary Tract Symptoms or ICSmale or ICSQoL or
International Continence Society-Benign Prostatic Hyperplasia study quality-of-life or MSHQ or Male Sexual Health Questionnaire
or (UROLIFE or TM-BPHQoL9) or Benign Prostatic Hypertrophy Health-Related Quality of Life Questionnaire or OAB-q or
(Overactive Bladder symptom and health-related quality of life questionnaire) or contilife or Quality of Life Assessment Questionnaire
ConcerningUrinary Incontinence orDetrusor Instability Score or I-QOLorUrinary Incontinence-SpecificQuality of Life Instrument
or ICIQ-FLUTS or International Consultation on Incontinence Questionnaire-Female Lower Urinary Tract Symptoms or ICIQ-
UI Short Form or International Consultation on Incontinence Questionnaire - Urinary Incontinence Short Form or Incontinence
Stress Index or King’s Health Questionnaire or MUDI or Male Urogenital Distress Inventory or musiq or Male Urinary Symptom
Impact Questionnaire or n-qol or Nocturia Quality of Life Questionnaire or pmses or Broome Pelvic Muscle Exercise Self-Efficacy
Scale or (Symptom Severity Index for stress incontinence in women or Symptom Impact Index for stress incontinence in women)
or uihi or Urinary Incontinence Handicap Inventory or Urinary Symptom Profile or yips or York Incontinence Perceptions Scale
or QUALIVEEN or QUALIVEEN-30 or SF-QUALIVEEN or QUALIVEEN Short Form or USS PROM or Urethral stricture
surgery patient-reported outcome measure or (Urogenital Distress Inventory or (U-IIQ or Urge-Incontinence Impact Questionnaire)
or (UIWQ or Urinary Incontinent Women Questionnaire) or (U-UDI or Urge-Urinary Distress Inventory) or (MMAP or Maine
Medical Assessment Program symptom index) or Prostate Outcomes Questionnaire or (PORPUS or Patient-oriented prostate utility
scale) or (HQLQ or Haemodialysis Quality of Life Questionnaire))) or (WURSS or Wisconsin Upper Respiratory Symptom Survey
or CMV-EYE or Quality of Life with Eye Disease or AIDS-HAQ or AIDS Health Assessment Questionnaire or HAT-QoL or
HIV-AIDS-Targeted Quality of Life or HIV-SI or HIV Symptom Index or HIV-SQUAD or Symptom Quality of Life Adherence
or HIV Overview of Problems - Evaluation System or MOS-HIV or Medical Outcome Study-HIV Health Survey or MPQOL
or Miami Pediatric Quality of Life Questionnaire Parent Scale or MQOL-HIV or Multidimensional Quality of Life questionnaire
for HIV-AIDS or HOIQ or Herpes Outbreak Impact Questionnaire or Herpes Symptom Checklist or RGHQoL or Recurrent
Genital Herpes Quality of Life Questionnaire or IIWS or Influenza Impact Wellbeing Scale or Influenza Symptom Severity scale or
Cuestionario Especifico en Condilomas Acuminados or (Genital Herpes Measure or HIV Assessment Tool or (HIV-QL31 or HIV-
Quality of Life - 31 items) or (Symptom Distress Module or HIV Symptom Index))) or (((Physical Performance Test or (Rosow
and Breslau Scale) or Rivermead Motor Assessment or Rivermead Mobility Index or Self Care Assessment Schedule or Situational
Control of Daily Activities or Timed Manual Performance Test or Nuclear Attitudes Questionnaire or Nurses’ Observational Scale
for Inpatient Evaluation or Relatives Stress Scale or Food Benefits Assessment or Nutritional Assessment Index or Nutrition Screening
Initiative self-assessment tool or Life Support PreferencesQuestionnaire or FamilyHistory Screen for Epidemiologic Studies or (Family
Adaptability and Cohesion Evaluation Scales) or Family Environment Scale or (HAPA or (Home Life and Personal Adaptation)) or
Marital Adjustment Test or (REFAMOS or Relationship with Family of Origin Scale) or Wisconsin Gait Scale or Hospital Admission
Risk Profile or (TOFHLA or Test of Functional Health Literacy in Adults) or (PRQ-2000 or Personal Resources Questionnaire-
2000) or (PRQ-85 or Personal Resource Questionnaire-85) or (NPQ-E or Nursing Practice Questionnaire-Education) or Physical
Activity Index or Physical Activity Scale or Specific Activity Scale or Weekly Activity Checklist or Resident Assessment Instrument
or (SCES or Sheltered Care Environment Scale) or (WOFS or Ward Organisational Features Scales) or Supervision Rating Scale or
(MRC-NCA or Medical Research Council - Needs for Care Assessment) or (Needs and Resources Assessment) or (PLNS or Patient
Learning Needs Scale) or (PRQC or Patient Rated Quality of Care) or (SATMED-Q or Treatment Satisfaction with Medicines
Questionnaire) or Trust in Physician Scale or Rosser Index of Disability or (MCSDS or (Marlowe and Crowne Social Desirability
Scale)) or (SSIn or Stereopsis Screening Inventory) or Work Performance Scale or Life Closure scale or Profile of Adaptation to Life or
(SDRS or Social Dysfunction Rating Scale) or (SAHD or Schedule of Attitudes toward Hastened Death) or (PADQ or Psychosocial
Aspects of Donation Questionnaire) or (NCSE or Neurobehavioral Cognitive Status Examination) or (RPAB or Rivermead Perceptual
Assessment Battery) or Trail-Making Test or (WAIS or Wechsler Adult Intelligence Scale) or Wechsler Memory Scale or (WMS-C or
Wechsler Memory Scale - Children) or Sense of Coherence Scale or Jalowiec Coping Scale or Multidimensional Coping Inventory or
(MEPSI or Modified Erikson Psychosocial Stage Inventory) or Food Frequency Questionnaire or Parenting Stress Index or (TRIG
or Texas Revised Inventory of Grief ) or Impact of Event Scale or (RLCQ or Recent Life Changes Questionnaire) or Schedule of
Recent Experience or (Levels of Attribution and Change) or Meaning of Illness Questionnaire or Multiple Locus of Control or
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(PHLOC or Parent Health Locus of Control scales) or (RIES or Revised Internal-External Scale) or Occupational Stress Inventory
or Life Orientation Test or Eysenck Personality Inventory or Karolinska Scales of Personality or (MMPI or Minnesota Multiphasic
Personality Inventory) or Maudsley Personality Inventory or Multidimensional Personality Questionnaire or PRF-Eor Personality
Research Form E or (MPOC or Measure of Processes of Care) or Treatment Services Review or Retirement Descriptive index or
(TSCS or Tennessee Self-Concept Scale) or (RSES or Rosenberg’s Self-Esteem Scale) or Self-Esteem Inventory or (SLSCL or Self-
Liking Self-Competence Scale) or (ISSI or Interview Schedule for Social Interaction) or Social Experiences Checklist or Social Problem
Questionnaire or Salience of Lifestyle Index or (SLDS or Satisfaction with Life Domains Scale) or (EASY-Care and sheffield) or Fisher
Grading Scale on Relation of CT SAH to Vasospasm or (ISAAC or (International Study of Asthma and Allergies in Childhood)) or
Injury Severity Score orMinimumData Set or (MEES orMainz Emergency Evaluation Score) orMuscle StrengthGrading or Ontario
Health Survey or (Papille Grading System for Subependymal and Germinal Matrix and Hemorrhage) or (PRAC-Test or (PRAgmatic
Content and face validity Test)) or (QLIV or Quality of Life Instrument Veterinary) or (RAPS or Rapid Acute Physiology Score) or
Revised Trauma Score or Spetzler AVMGrading System or Trauma Score or Time Trade Off or (Health and work Questionnaire) or
Health-related quality of life questionnaire for women with polycystic ovary syndrome or Alzheimer’s disease related quality of life or
satisfaction with life scale or A-RHDQoL or Age-Related Hormone Deficiency-Dependent Quality of Life Questionnaire or AQLQ
or Asthma Quality of Life Questionnaire or Chronic Respiratory Disease Questionnaire or QUOLIS or Quality of Life Interview
Schedule or Paediatric Asthma Quality of Life Questionnaire or SQLP or Subjective Quality of Life Profile or ADDQOL or Audit of
Diabetes Dependent Quality of Life or DSQOLS or Diabetes Specific Quality of Life Scale or RetDQoL or Retinopathy Dependent
QoL or GQLQ or Geriatric Quality of Life Questionnaire or Patient-Specific Index or HDQoL or Hormone Deficiency-dependent
Quality of Life or ThyDQoL or Thyroid-Dependent Quality of Life or JAQQ or Juvenile Arthritis Quality of life Questionnaire or
KPSI or Knee Patient-Specific Index or MacDQoL or Macular Disease-Dependent Quality of Life or QLI-MH or Quality of Life
Index for Mental Health or PGPQ or Patient-Specific Functional Scale or OA GO AWAY or RDQOL or Renal-Dependent Quality
of Life or MACTAR or McMaster-Toronto Arthritis Patient Preference Disability Questionnaire or Problem Elicitation Technique
or SCI-SET or Spinal cord injury spasticity evaluation tool or Meaning in Life Depth or LLATBI or Living Life After Traumatic
Brain Injury or EyeDQoL or Eye-Dependent Quality of Life or (Experienced Meaningfulness and Meaninglessness Questionnaire)
or Interview on Meaning in Life or SBQOL or SmithKline-Beecham Quality of Life Index or SmithKline-Beecham Quality of Life
Index Scale or Helpful Aspects of Therapy or (Duggan and Dijkers) or (Gottschalk and Lolas) or Fulfilment of Meaning Scale or
Meaning Essay Document or Personal Meaning Systems or Questionnaire of Life Meaning Sources or (Personal questionnaire and
shapiro) or (Impact on Roles and Functioning Scale) or Perceived Control of Daily Activities Scale or Family Quality of Life Survey
or Longer term Unmet Needs after Stroke or Impact of dry eye on everyday life or Psychosocial Rehabilitation Outcomes Toolkit
or Patient-Generated Subjective Global Assessment or Toronto outcome measure for craniofacial prosthetics or Quality of Life for
Respiratory IllnessQuestionnaire or Scale for the Assessment of Positive Symptoms or Scale for the Assessment of Negative Symptoms
or mini Asthma Quality of Life Questionnaire or Separation Anxiety Daily Diary or Patient-Generated Subjective Global Assessment
or Social Support Network Inventory or Norbeck social support questionnaire or Quality of Life Self-Assessment Inventory or Inter-
goal Relations Questionnaire or Personal Projects Analysis or CFS Sense of Control scale or Carolina Index of Self-Regulation or
COPD Self Efficacy Scale or UCSD Shortness of Breath Questionnaire or Recurrent Genital Herpes Quality of Life Questionnaire
or Baseline dyspnea index or FertiQoL or ABILHAND-Kids or Schizotypal Personality Questionnaire or Personal Wellbeing Index
or Cystic Fibrosis Coping Scale or Cystic Fibrosis Quality of Life Questionnaire or Taylor Manifest Anxiety Scale or Functional
Assessment of Cancer Therapy General or Anderson Symptom Inventory or Functional Assessment of Chronic Illness Therapy or
Cancer Therapy Satisfaction Questionnaire or (Child and Adolescent Functional Assessment Scale) or Temporomandibular joint
questionnaire or Eating Disorders Quality of Life or Marks Asthma Quality of Life Questionnaire or Health Status Questionnaire
or Quality of Life in Epilepsy Inventory for Adolescents or BOMET-QoL or Global Initiative for Asthma or Asthma Control Test
or Fear of Cancer Recurrence or Mental Adjustment to Cancer or CHOICE Health Experience Questionnaire or System of Belief
Inventory or Multidimensional Scale of Perceived Social Support or Quebec back pain disability scale or Bath Spondylitis Functional
Index or Patient Needs Scale or Revised Children Manifest Anxiety Scale or Separation Anxiety Inventory for Children or Inventory
for the Assessment of Quality of Life in Children) and Adolescents) or Kansas City Cardiomyopathy Questionnaire or Headache-
Specific Locus of Control Scale or Oral Health Impact Profile or international index of erectile function or Sexual Life Quality
Questionnaire or Questionnaire of quality of life in patients with primary hyperhidrosis or Tinnitus Handicap Inventory or Hearing
Handicap Inventory or Satisfaction with Life Scale or Good death Inventory or Impact of Weight on Quality of Life inventory or
Fibromyalgia Impact Questionnaire or McGill Quality of Life questionnaire or Reciprocal Social Support Scale or questionnaire for
26Routine provision of information on patient-reported outcome measures to healthcare providers and patients in clinical practice
(Protocol)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
satisfaction of hospitalized patients or Living With Asthma Questionnaire or Rhinasthma questionnaire or Zerssen list of complaints
or COPM or Canadian Occupational Performance Measure or CoMQoL or Comprehensive Quality-of-Life scale or (Quality of Life
Index and ferrans) or qols or (Quality of Life Scale and flanagan) or IQOLI or Individual Quality of Life Interview or MYCaW or
(Measure Yourself Concerns and Wellbeing) or MYMOP or Measure Yourself Medical Outcome Profile or Patient Generated Index
or QOLAS or Quality of Life Assessment Schedule or QLSI or Quality of Life Systemic Inventory or FLZM or Questions on Life
Satisfaction or SEIQoL or Schedule for the Evaluation of Individual Quality of Life or SEIQol-DW or SEIQoL-Direct Weighting
or Schedule for Meaning in Life Evaluation or SDQLM or Subjective Domains of quality of life measure or Goal attainment scale or
PSYCHLOPS or Psychological Outcome Profiles or QoL-GAP or QOLI or Quality of Life Inventory or SQLP or Subjective Quality
of Life Profile or W-QLI or Wisconsin Quality of Life Index or Zung Self Rating Depression Scal* or Zung Self-Rating Depression
Scal* or Center for Epidemiologic Studies Depression)).tw
#46 44 or 45
#47 (visit or visits or appointment* or consultation*).tw.
#48 (monitor* or screen* or management or follow-up* or followup* or follow up*).tw
#49 ((clinical or medical or dental or general or family or surgical) adj practice).tw
#50 47 or 48 or 49
#51 exp feedback/ or (feedback or fed back).tw.
#52 exp decision making/ or decision making.tw. or exp communication/ or communication.tw. or exp physician-patient relations/
#53 51 or 52
#54 (randomised controlled trial or controlled clinical trial).pt. or random*.ab. or trial.ti. or placebo.ab. or clinical trials as topic.sh
#55 46 and 50 and 53 and 54
#56 exp animals/ not humans.sh.
#57 55 not 56
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